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A B S T R A C T
Background
Recruiting participants to trials can be extremely difficult. Identifying strategies that improve trial recruitment would benefit both
trialists and health research.
Objectives
To quantify the effects of strategies to improve recruitment of participants to randomised controlled trials.
Search methods
We searched the CochraneMethodology Review Group Specialised Register (CMR) 2010, Issue 2, part of The Cochrane Library (online)
www.thecochranelibrary.com (searched 16 April 2010); MEDLINE, Ovid (1950 to March Week 5 2010) (searched 14 April 2010);
EMBASE, Ovid (1980 to 2010 Week 14) (searched 14 April 2010); ERIC, CSA (1966 to 14 April 2010); Science Citation Index
Expanded, ISI Web of Science (1975 to 14 April 2010); Social Sciences Citation Index, ISI Web of Science (1975 to 14 April 2010);
National Research Register (online) (Issue 3 2007) (searched 3 September 2007); C2-SPECTR (searched 9 April 2008) and PubMed
’Related citations’ (searched 4 June 2010)
Selection criteria
Randomised and quasi-randomised controlled trials of methods to increase recruitment to randomised controlled trials. This includes
non-healthcare studies and studies recruiting to hypothetical trials. We excluded studies aiming to increase response rates to question-
naires or trial retention, or which evaluated incentives and disincentives for clinicians to recruit patients.
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Data collection and analysis
We extracted data on: the method evaluated; country in which the study was carried out; nature of the population; nature of the study
setting; nature of the study to be recruited into; randomisation or quasi-randomisation method; and numbers and proportions in each
intervention group. We used a risk or odds ratio and their 95% confidence interval (CI) to describe the effect in individual trials. We
assessed heterogeneity between trial results.
Main results
We identified 45 eligible trials (18 new to this update) withmore than 41,239 participants. There were 40 studies involving interventions
aimed directly at trial participants, while five evaluated interventions aimed at people recruiting participants. All studies were in health
care.
Some interventions were effective in increasing recruitment: telephone reminders to non-respondents (odds ratio (OR) 1.95, 95% CI
1.04 to 3.66; two trials, 1058 participants), use of opt-out, rather than opt-in, procedures for contacting potential trial participants (RR
1.39, 95% CI 1.06 to 1.84; one study, 152 participants) and open designs where participants know which treatment they are receiving
in the trial (RR 1.22, 95% CI 1.09 to 1.36; two studies, 4833 participants). However, some of these strategies have disadvantages,
which may limit their widespread use. For example, opt-out procedures are controversial and open designs are by definition unblinded.
The effects of many other recruitment strategies are unclear; examples include the use of video to provide trial information to potential
participants and modifying the training of recruiters. Many studies looked at recruitment to hypothetical trials and it is unclear how
applicable these results are to real trials.
Authors’ conclusions
There are promising strategies for increasing recruitment to trials: telephone reminders; requiring potential participants to opt-out of
being contacted by the trial team regarding taking part in a trial, rather than them having to opt-in, and open designs. Some strategies
(e.g. open trial designs) need to be considered carefully before use because they also have disadvantages. For example, opt-out procedures
are controversial and open designs are by definition unblinded.
P L A I N L A N G U A G E S U M M A R Y
Strategies to recruit participants to randomised trials
Many trials do not recruit sufficient participants and this can make it more difficult to use the results of the research in practice. Effective
strategies for improving recruitment would be of great benefit to researchers designing and running trials. This review did find some
strategies that can increase recruitment to trials. Researchers could telephone non-respondents to remind them about the trial. The
research team could use opt-out, rather than opt-in, procedures for contacting potential trial participants, or they could use an open
design where participants know which treatment they are receiving in the trial, rather than having some of them receive a placebo or
dummy intervention to mask this. However, some of these effective strategies have disadvantages, which may limit their widespread
use. The effect of many other recruitment strategies is unclear. Many studies have looked at recruitment to mock trials and it is difficult
to know how their findings would apply to real trials. It would be better if more researchers included an evaluation of recruitment
strategies in real trials.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Telephone reminder versus no telephone reminder
Patient or population: Individuals eligible for a trial
Settings: Any
Intervention: Telephone reminder
Comparison: No telephone reminder
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
No telephone reminder Telephone reminder
Number recruited Low1 OR 1.95
(1.04 to 3.66)
778
(2 studies)
⊕⊕⊕©
moderate2
30 per 100 46 per 100
(31 to 61)
Moderate1
50 per 100 66 per 100
(51 to 79)
High1
70 per 100 82 per 100
(71 to 90)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; OR: Odds ratio;
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 The low, moderate and high illustrative recruitment levels of 30%, 50% and 70% were selected based on our prior experience with trial
recruitment.
2 There was moderate heterogeneity, I2 = 59%.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
Randomised controlled trials are the gold-standard for the evalua-
tion of the effectiveness and safety of healthcare interventions, par-
ticularly because they protect against selection bias (Kunz 2007).
However, recruiting clinicians and patients to randomised trials
can be extremely difficult.
Poor recruitment can lead to an underpowered study, which may
report clinically relevant effects to be statistically non-significant.
In such cases, it is important to bear in mind that absence of evi-
dence of a difference is not evidence of the absence of a difference
(Altman 1995). A non-significant finding increases the risk that
an effective intervention will be abandoned before its true value is
established, or that there will be a delay in demonstrating this value
while more trials or meta-analyses are done. Underpowered trials
also raise an ethical problem: trialists have exposed participants to
an intervention with uncertain benefit but may still be unable to
determine whether the intervention does more good than harm
on completion of the trial. Poor recruitment can also lead to the
trial being extended, which increases cost.
Although investigations of recruitment differ in their estimates of
the proportion of studies that achieve their recruitment targets, it
is likely that less than 50% meet their target, or meet their tar-
get without extending the length of the trial (Charlson 1984; Foy
2003; Haidich 2001; McDonald 2006). For example, McDonald
et al found that only 38 (31%) of the 114 trials achieved their orig-
inal recruitment target and 65 (53%) were extended (McDonald
2006). The overall start to recruitment was delayed in 47 (41%)
trials and early recruitment problems were identified in 77 (63%)
trials. Foy et al studied seven primary care trials of dyspepsia man-
agement and only one achieved its recruitment target; five re-
cruited less than 50% of their target and three of these closed pre-
maturely because of recruitment problems (Foy 2003).
Trialists use many interventions to improve recruitment (see for
example Caldwell 2010, Watson 2006 and Prescott 1999) but it
is generally difficult to predict the effect of these interventions.
This Cochrane Methodology Review was preceded by an earlier
Cochrane review by Mapstone et al (Mapstone 2007), and was
published first in 2010 using a revised search strategy focused on
interventions to improve recruitment to randomised controlled
trials (rather than to research studies in general) and aimed, among
other things, to consider the effect of study setting on recruitment
(Treweek 2010). We have updated that work in this version of the
review.
O B J E C T I V E S
The primary objective is to quantify the effects of strategies to im-
prove recruitment of participants to randomised controlled trials.
A secondary objective is to assess the evidence for the effect of
the research setting (e.g. primary care versus secondary care) on
recruitment.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised and quasi-randomised controlled trials of interven-
tions to improve recruitment of participants to randomised con-
trolled trials.
Types of data
Randomised and quasi-randomised controlled trials of recruit-
ment strategies set in the context of trials but not limited to health
care; since interventions that work in other fields could be ap-
plicable to healthcare settings. Strategies both within real settings
and in hypothetical trials (studies that ask potential participants
whether they would take part in a trial if it was run, but the trial
does not actually exist) are eligible.We excluded research into ways
to improve questionnaire response and research looking at incen-
tives and disincentives for clinicians to recruit patients to trials as
these issues are addressed by complementary Cochrane Method-
ology Reviews (Edwards 2009; Rendell 2007). Studies of reten-
tion strategies were also excluded as a Cochrane Methodology Re-
view on strategies to reduce attrition from trials is being prepared
(Brueton 2011).
Types of methods
Any intervention that aimed to improve recruitment of partici-
pants to a randomised controlled trial. The interventions being
studied could be directed at potential participants (e.g. patients
being randomised to a trial), collaborators (e.g. clinicians recruit-
ing patients for a trial), or others (e.g. research ethics committees).
Examples of such interventions are letters introducing the trial
being signed by eminent people, alternative methods of providing
information about the trial to potential participants, additional
training for collaborators, monetary incentives for participants,
telephone follow-up of expressions of interest and modifications
to the design of the trial (e.g. using a preference design).
Types of outcome measures
Primary outcomes
• Proportion of eligible individuals or centres recruited.
Secondary outcomes
• Rate at which participants were recruited.
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Search methods for identification of studies
We searched the following electronic databases without language
restriction for eligible studies:
• The Cochrane Methodology Review Group Specialised
Register (CMR) 2010, Issue 2, part of The Cochrane Library
(online) www.thecochranelibrary.com (searched 16 April 2010);
• MEDLINE, Ovid (1950 to March Week 5 2010) (searched
14 April 2010);
• EMBASE, Ovid (1980 to 2010 Week 14) (searched 14
April 2010);
• ERIC, CSA (1966 to date of search) (searched 14 April
2010);
• Science Citation Index Expanded, ISI Web of Science
(1975 to 14 April 2010);
• Social Sciences Citation Index, ISI Web of Science (1975 to
14 April 2010);
• National Research Register (online) (Issue 3 2007)
(searched 3 September 2007);
• C2-SPECTR (searched 9 April 2008); and
• PubMed ’Related citations’ (searched 4 June 2010).
The UK Cochrane Centre developed and ran a series of search
strategies in MEDLINE in 2000 to identify reports of method-
ological studies and records for such studies that were identified
have been added to CMR. A series of search strategies for method-
ology studies had also been developed and run in EMBASE in
2004. Therefore, to increase the efficiency of our searches and to
retrieve records not yet entered into CMR, our search of MED-
LINE was limited to records entered from 2001 and, for EM-
BASE, we limited the search to records entered from 2005. The
UK National Research Register was archived in September 2007
which is why it has not been searchedmore recently (see UK Clin-
ical Trials Gateway portal.nihr.ac.uk/Pages/NRRArchive.aspx).
We searched PubMed to retrieve ’related articles’ for 27 stud-
ies included in the earlier version of this review (Avenell 2004;
Bentley 2004; Cooper 1997; Coyne 2003; Diguiseppi 2006; Du
2008; Ford 2004; Fowell 2006; Fureman 1997; Gallo 1995;
Graham 2007; Hemminki 2004; Ives 2001; Kendrick 2001;
Kimmick 2005; Larkey 2002; Liénard 2006; Llewellyn-Thomas
1995a; Llewellyn-Thomas 1995b; Monaghan 2007; Myles 1999;
Nystuen 2004; Simel 1991; Simes 1986; Trevena 2006; Welton
1999; Weston 1997).
The full search strategies for all databases are included in Appendix
1.
Data collection and analysis
Wehave included the protocol for this updated review inAppendix
2 tomake it available alongside this review inThe Cochrane Library.
Selection of studies
Two review authors independently screened the titles and abstracts
of all references identified by the search strategy. The full versions
of papers not definitely excluded at that stage were obtained for
detailed review. Two review authors independently assessed all po-
tentially eligible studies to determine if they met the inclusion cri-
teria. Where differences of opinion occurred, these were discussed
and, when necessary, a third review author read the full papers.
Data extraction and management
Two review authors (ST and one of PL, EM or MP) indepen-
dently carried out data extraction of each included article (using
a proforma specifically designed for the purpose). Differences in
data extraction were resolved by discussion. We extracted data on
the method evaluated; country in which the study was carried out;
nature of the population; nature of the study setting; nature of
the study to be recruited into; randomisation or quasi-randomi-
sation method; and numbers and proportions of participants in
the intervention and comparator groups of the study comparing
recruitment strategies.
Assessment of risk of bias in included studies
We assessed the adequacy of allocation concealment (adequate,
unclear and inadequate) for each study (Schulz 1995). We also
considered other aspects of methodological quality, such as com-
pleteness of reporting of results and loss to follow-up. Data on
methodological quality are presented in an additional table for all
included studies. We assessed completeness of reporting with ref-
erence to the ability to judge whether allocation was concealed (i.e.
unclear for allocation concealment implies incomplete reporting)
but also with regard to clear information on participants, interven-
tion, comparator and outcome measure. We recorded reporting
of information on the flow of participants through the trial (e.g.
from a CONSORT diagram).
We interpreted results in light of methodological quality but we
did not exclude studies because of low quality. The risk of bias is
summarised in line with the guidance in the Cochrane Handbook
for Systematic Reviews of Interventions (version 5.0.1, Handbook
2008), namely: A: Low risk of bias; B: Moderate risk of bias;
C: High risk of bias. We considered concealment of allocation
(adequate versus inadequate or unclear) as a potential cause of
heterogeneity in subgroup analysis, where there were sufficient
studies.
Analysis
Trials have been grouped according to the type of intervention
(e.g. monetary incentives, alternative forms of consent). Interven-
tions have been grouped where they were similar in form and
content. We combined binary data as risk ratios (RR) with the
associated 95% confidence intervals (CIs) where sufficient data
were available. We only included cluster-randomised trials in the
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meta-analysis if sufficient data were reported to allow inclusion
of analyses that adjusted for clustering in which case we used an
odds ratio (OR) as the summary effect in the meta-analysis re-
sult. We planned pre-specified subgroups (target group, setting,
recruitment to real versus hypothetical trial) if sufficient studies
were available.
Assessment of heterogeneity
We sought statistical evidence of heterogeneity of results of trials
using the Chi2 test for heterogeneity and quantified the degree
of heterogeneity observed in the results using the I2 statistic (
Higgins 2003). Where substantial heterogeneity was detected, we
informally investigated possible explanations and summarised the
data using a random-effects analysis if appropriate. We planned
to explore the following factors in subgroup analyses, assuming
enough studies were identified, as we believed that these were
plausible explanations for heterogeneity.
• Type of design used to evaluate recruitment strategies
(randomised versus quasi-randomised) and concealment of
allocation (adequate versus inadequate or unclear).
• Setting of the study recruiting participants (e.g. primary
versus secondary care; healthcare versus non-healthcare settings).
• Design of the study recruiting participants (e.g. open versus
blinded studies, trials with placebo arms versus those without).
• Target group (e.g. ethics committees, clinicians, patients).
• Recruitment to hypothetical versus real trials.
Assessment of reporting biases
We investigated reporting (publication) bias for the primary out-
comes using a funnel plot where 10 or more studies were available.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of studies awaiting classification.
See Characteristics of included studies; Characteristics of excluded
studies.
We screened a total of 16,334 titles and abstracts (6701 in this up-
date) and needed the full text of 301 (81 in this update) articles to
confirm inclusion, or address uncertainties among review authors
as to whether the article should be included, generally due to the
lack of an abstract. We were able to obtain the full text of 297 of
these articles. The remaining four articles were not obtained for
this version of the review because the title or abstract reference
was incomplete or incorrect. We translated three articles from the
previous version of this review into English for this update, two
from Spanish and one from Italian.
Additionally, we retrieved the full text of 10 articles identified by
checking the reference lists of reviews picked up by the updated
search and of one article (Free 2010) published outside the search
period but which looked relevant (it was and is one of the included
studies). Of the 308 articles for which full text was obtained, 45
were eligible for inclusion. One previously included study (Gallo
1995) now has a new primary reference as an article originally
published in Italian (Perrone 1995) reportedmore data thanGallo
1995.
There were 40 studies involving interventions aimed directly at
trial participants and five evaluated interventions aimed at those
recruiting participants. More than 41,239 individuals were in-
volved in the 45 studies; it was not clear how many participants
were recruited in two studies, both of which involved interven-
tions aimed at recruiters, rather than those being recruited. The
figure of 41,239 includes both individuals who were recruited to
randomised controlled trials, as well as those who were approached
about recruitment but declined.
We evaluated six categories of intervention, all of which were used
in connection with healthcare studies. There were too few studies
evaluating the same or similar interventions to allow us to do any
of our planned subgroup analyses.
Risk of bias in included studies
See Characteristics of included studies; Figure 1; Figure 2.
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Figure 1. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 2. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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All studies were described by their authors as either randomised
(41 studies) or quasi-randomised (four studies). We considered
allocation concealment to have been present for 23 studies, not
clear for 15 and not met for seven. We considered the overall
assessment of the risk of bias as low risk of bias for 12 studies,
moderate risk of bias for 13 studies and high risk of bias for 20
studies.
Effect of methods
See: Summary of findings for the main comparison Telephone
reminder versus no telephone reminder; Summary of findings 2
OpenRCT versus blinded RCT; Summary of findings 3Consent
to experimental care versus usual consent; Summary of findings
4 Consent to standard care versus usual consent; Summary of
findings 5 Educational audiovisual information versus standard
information; Summary of findings 6 Study-related questionnaire
+ trial invitation versus trial invitation; Summary of findings
7 Clinical trial booklet + standard information versus standard
information
We placed the recruitment interventions into six broad categories.
One (Modification to the consent form or processes) included
seven variations on consent procedures while another (Modifica-
tion to the approach made to potential participants) included 28
variations on the way potential trial participants were approached
about the trial (see Table 1). Although these two categories each
contain several studies, we considered the majority of interven-
tions to be sufficiently different to make pooling them inappro-
priate.
The lines between categories were not always clear. We placed
studies according to the emphasis given by the original authors of
the study. For example, although Fowell 2006 involved a change
to consent procedures, we placed it under ’Design change’ because
the authors’ emphasis was on the use of cluster-randomisation to
increase recruitment. Our six categories are as follows.
• Design changes
◦ Open RCT versus blinded RCT
◦ Placebo versus other comparator
◦ Patient preference design versus conventional RCT
design
• Modification to the consent form or process
◦ Opt-out consent versus opt-in consent
◦ Consent to experimental care versus usual consent
◦ Consent to standard care versus usual consent
◦ Refusers choose treatment versus usual consent
◦ Physician-modified consent versus usual consent
◦ Participant-modified consent versus usual consent
◦ Researcher reading our consent versus participant
reading consent
• Modification to the approach made to potential participants
◦ Educational audiovisual information versus standard
information
◦ Educational audiovisual information with written
information versus written information
◦ Educational audiovisual information + help versus
standard information + general audiovisual information + help
◦ Telephone reminder versus no telephone reminder
◦ Telephone reminder + questionnaire versus no
reminder or questionnaire
◦ Telephone screening versus face-to-face screening
◦ SMS messages containing quotes from existing
participants versus no messages
◦ Enhanced recruitment package + recruitment at
churches versus standard recruitment package
◦ Enhanced recruitment package versus standard
recruitment package
◦ Enhanced recruitment package + baseline data over
telephone versus standard recruitment package
◦ Electronic completion of screening questionnaire
versus standard paper completion
◦ Oral completion of screening questionnaire versus
standard paper completion
◦ Study-related questionnaire + trial invitation versus
trial invitation
◦ Clinical trial booklet + standard information versus
standard information
◦ Negative framing of side effects versus neutral framing
◦ Positive framing of side effects versus neutral framing
◦ Less detailed presentation of risk and other
information versus more detailed presentation
◦ Information leaflet with explanation versus
information leaflet without explanation
◦ Brief counselling + print materials versus print
materials
◦ Emphasising pain in information versus standard
information
◦ Emphasising risk in information versus standard
information
◦ Newspaper article + study information versus study
information only
◦ More favourable newspaper article + study
information versus less favourable article + study information
◦ Interactive computer presentation of trial information
versus standard paper presentation
◦ Interactive computer presentation of trial information
versus audio-taped presentation
◦ Writing treatment effect is ’twice as fast’ in trial
information versus writing ’half as fast’
◦ Total information disclosure versus standard disclosure
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◦ One new versus both standard (description of
intervention)
◦ Screening by senior investigator versus screening by
research assistant
• Financial incentives for participants
• Financial incentives for participants
• Modification to the training given to recruiters
• Greater contact between trial co-ordinator and trial sites
We produced ’Summary of findings’ tables for all interventions
where more than one study was available, giving seven in to-
tal (Summary of findings for the main comparison; Summary
of findings 2; Summary of findings 3; Summary of findings 4;
Summary of findings 5; Summary of findings 6; Summary of
findings 7).
Design changes
Six studies (5665 participants; one study also recruited 28 general
practices) considered the effect of trial design changes on recruit-
ment; five involved real trials, one a hypothetical trial. Two studies
(Avenell 2004 (fracture prevention trial); Hemminki 2004 (post-
menopausal hormone therapy trial)) compared an open design
(participants knowwhat treatment they are receiving) to a blinded,
placebo-controlled design. An open design improved recruitment
(RR 1.22, 95% CI 1.09 to 1.39) (Analysis 1.1; Summary of
findings 2).
Welton 1999 investigated the effect of a placebo group on willing-
ness of women to take part in a hypothetical hormone replacement
trial and found that the number of women who would definitely
or probably take part may be less with a placebo as comparator
(RR 0.76, 95% CI 0.59 to 0.99) (Analysis 2.1). It was not clear
whether participants were told what the placebo would be (e.g. a
tablet that did not contain an active ingredient) and the applica-
bility of this result to real trials is unclear.
Three studies looked at other trial design changes. Cooper 1997
compared recruitment in a partially randomised patient preference
design (participants with a strong preference for one treatment
or another receive it, while the remainder are randomised) with a
conventional randomised design for a trial of management strate-
gies for heavy menstrual bleeding. Of the 135 women allocated
to the preference arm, 40 had a strong preference for a particu-
lar treatment, 90 were willing to be randomised and five refused.
Those allocated to the preference design were more likely to agree
to take part in the study as a whole (RR 1.37, 95% CI 1.22 to
1.53) but this made little or no difference to recruitment to the
randomised trial (Analysis 3.1). Fowell 2006 compared cluster-
randomisation in a palliative care trial to individual consent after
randomisation if the participant was randomised to the experi-
mental treatment (sometimes called a Zelen design) in a cross-over
trial. The study had only two sites (clusters) with few participants:
6 out of 24 potential participants were recruited in the cluster
arm, compared to 0 out of 29 in the Zelen arm. Litchfield 2005
compared internet-based, electronic data collection with paper-
based data collection in a cluster-randomised trial of two delivery
systems for insulin. Improving general efficiency, not recruitment,
was the aim of the study but recruitment data were presented. The
14 practices allocated to electronic data collection recruited 45/
52 patients screened, while the 14 using paper recruited 28/28
patients. The difference was significant (P = 0.04).
Modification to the consent form or process
Five studies (4824 participants) evaluated the effect of changes to
the consent form or consent process; three involved real trials, two
hypothetical trials. The effect of participants having to contact
the trial team to take part in a trial (opt-in) compared to having
to contact the trial team if they did not wish to be approached
about the trial (opt-out) was studied by Trevena 2006 in a trial
of decision aids for screening of colorectal cancer by faecal occult
blood testing. Opt-out improved recruitment (RR 1.39, 95% CI
1.06 to 1.84) (Analysis 4.1).
Two studies involving recruitment to hypothetical trials (Perrone
1995 (trial of a hypothetical new drug); Myles 1999 (anaesthesia
trial)) evaluated various combinations of prerandomisation and
consent (e.g. prerandomised consent to receive the experimen-
tal treatment). Two interventions were common between the two
studies: a) seeking consent to receive the experimental treatment
and b) seeking consent to receiving the standard treatment. Seek-
ing consent to receive experimental treatment probably leads to
little or no difference in recruitment (Analysis 5.1; Summary of
findings 3). Seeking consent to receive the standard treatment
probably decreased recruitment (RR 0.66, 95% CI 0.60 to 0.71)
but there was considerable heterogeneity (I2 = 93%) (Analysis 6.1;
Summary of findings 4). Under a random-effects model there may
not be an increase in recruitment (RR 0.76, 95%CI 0.49 to 1.17).
There were three other comparisons in these two studies that were
not common to both:
• usual consent compared to a consent process that allowed
those refusing to be randomised to choose whether they wanted
the experimental or standard treatment (Perrone 1995);
• usual consent compared to consenting to a 7 in 10 chance of
getting the experimental treatment because the clinician believes
experimental treatment is more effective (Myles 1999); and
• usual consent compared to consenting to the participant
selecting the chance (6, 7 or 8 in 10) of receiving the
experimental treatment (Myles 1999).
All three interventions probably led to little or no difference in
recruitment (Analysis 7.1; Analysis 8.1; Analysis 9.1).
In a smoking cessation trial, Wadland 1990 investigated the effect
of a researcher reading out the consent form compared to the po-
tential participant reading it; this may not lead to any difference in
recruitment (Analysis 10.1). Coyne 2003 ran a cluster trial involv-
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ing 44 oncology centres to compare a consent form designed to
be easy to read with the organisation’s standard consent form. Al-
though the authors did not present centre-level recruitment data,
or provide an intracluster correlation coefficient, they did consider
intracluster correlation in their analysis and found that recruit-
ment did not differ significantly between the two trial groups (P
= 0.32).
Modification to the approach made to potential participants
Twenty-eight studies involving trial participants (28,618 partici-
pants) and one involving the centres that recruit participants (126
centres) evaluated the effect of modifying trial information, or the
way it was delivered. Fourteen of the studies involved real trials,
14 hypothetical trials. NB. One study (Free 2010) also evaluated
a financial incentive and appears in that category as well (See Fi-
nancial incentives for participants).
Six studies investigated the use of educational videos. Three (Du
2009, Du 2008 and Hutchison 2007) investigated the effect of
video presentation of information about trials and randomisation
on recruitment to a range of therapeutic and non-therapeutic can-
cer trials but the intervention probably led to little or no differ-
ence in recruitment (Analysis 11.1; Summary of findings 5); there
was moderate heterogeneity (I2 = 50%). Weston 1997 compared
the effect on willingness to participate of a 10-minute video plus
written information versus written information only in a trial eval-
uating management policies for pregnant women with prelabour
rupture of membranes. The video probably improved willingness
to participate (RR 1.75, 95% CI 1.11 to 2.74) (Analysis 12.1).
Jeste 2009 presented key trial information to participants using a
DVD while a research assistant was available to answer any ques-
tions to support recruitment of healthy volunteers and individuals
with schizophrenia to a hypothetical trial. This probably led to
little or no difference in recruitment compared to just having the
research assistant to answer questions (Analysis 13.1). Fureman
1997 used a 26-minute video as supplement to a pamphlet to try
and improve willingness to take part in a hypothetical preventive
HIV vaccine trial. The number of individuals willing to take part
was not presented in the published paper but willingness as mea-
sured on a composite 0 to 4 score was higher in the video group
(1.69) than in the pamphlet-only group (1.50) up to two months
after seeing the video, although this difference was not statistically
significant.
Telephones were used in four studies; three using voice (Harris
2008; Diguiseppi 2006; Nystuen 2004) and one using text mes-
sages (Free 2010). Nystuen 2004 and Harris 2008 evaluated the
effect of telephone reminders on recruitment to a trial investigat-
ing an intervention to support sick-listed individuals get back to
work (Nystuen 2004) and a physical activity trial in older people
(Harris 2008). Telephone reminders improved recruitment (odds
ratio 1.95, 95%CI 1.04 to 3.66) although there wasmoderate het-
erogeneity (I2 = 59%) (Analysis 14.1; Summary of findings for the
main comparison) in terms of the magnitude of the effect. Harris
2008 also combined telephone reminders with a study-related
questionnaire sent together with the invitation letter, which led to
little or no difference in recruitment (Analysis 15.1). Diguiseppi
2006 compared the effect on willingness to participate in a hypo-
thetical future lifestyle change trial of telephone screening for haz-
ardous drinking versus face-to-face administration in the clinic.
Telephone screening may have improved willingness to take part
compared to face-to-face administration (RR 1.26, 95% CI 1.06
to 1.50) (Analysis 16.1). Free 2010 sent a series of four text mes-
sages with quotes from existing participants to potential partici-
pants in a smoking cessation trial and this improved recruitment
(RR 35.09, 95% CI 2.12 to 581.48) (Analysis 17.1) although the
small numbers recruited overall led to a very wide confidence in-
terval.
Ford 2004 developed three enhanced recruitment interventions to
recruit African Americans to a cancer trial. The enhancements in-
cluded using African Americans to conduct screening interviews,
collecting baseline information by telephone rather than mailed
questionnaire and face-to-face recruitment sessions at African
American churches. These were compared to the standard recruit-
ment procedure. The most intense intervention, which included
the church sessions, probably led to an improvement in recruit-
ment (RR 1.37, 95% CI 1.05 to 1.78) (Analysis 18.1). The two
other interventions probably led to little or no difference in re-
cruitment (Analysis 19.1; Analysis 20.1). Graham 2007 compared
the effect on willingness to take part in a hypothetical lifestyle
change trial of electronic, oral and paper-and-pencil completion
of a screening questionnaire. These interventions may not have
led to any difference in recruitment (Analysis 21.1; Analysis 22.1).
Harris 2008 andKendrick 2001 bothmailed study-relevant (phys-
ical activity and injury prevention, respectively) questionnaires to
potential participants together with invitation letters but this led
to little or nodifference in recruitment (Analysis 23.1; Summary of
findings 6). We identified three other interventions that involved
booklets:
• two compared standard information compared to a clinical
trial information booklet plus standard trial information, one for
a hypothetical breast cancer trial (Ellis 2002), the other a real
trial for HIV patients (Ives 2001);
• neutrally-framed information on side effects in a colon
cancer trial compared to negatively-framed information
(Llewellyn-Thomas 1995a); and
• neutrally-framed information on side effects in a colon
cancer trial compared to positively-framed information
(Llewellyn-Thomas 1995a).
All three interventions probably led to little or no difference in re-
cruitment (Analysis 24.1 (Summary of findings 7); Analysis 25.1;
Analysis 26.1). There was probably little or no difference in re-
cruitment from using a less detailed information leaflet rather than
a more detailed leaflet in a hypothetical intensive care trial (Freer
2009) (Analysis 27.1). This result was not improved by providing
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an verbal explanation with the leaflet (Analysis 28.1). Mandelblatt
2005 added a brief verbal education session to standard printed
participant information leaflets and this may improve recruitment
slightly compared to print materials alone (Analysis 29.1). Em-
phasising howpainful, or risky, trial procedures were in participant
information for a hypothetical surgery trial probably decreases re-
cruitment slightly in both cases (Treschan 2003; RR 0.55, 95%
CI 0.36 to 0.85; RR 0.41, 95% CI 0.24 to 0.68) (Analysis 30.1;
Analysis 31.1). It is unclear how applicable this result is to real
trials.
Pighills 2009 investigated the effect of providing a newspaper arti-
cle about the trial together with the standard participant informa-
tion but this probably led to little or no difference in recruitment
(Analysis 32.1). Replacing the newspaper article with one that was
more favourable to the trial did not change this result (Analysis
33.1). Weinfurt 2008a investigated the effect of investigators’ fi-
nancial disclosure on recruitment to a hypothetical heart disease
trial by presenting participants with one of three scenarios where
the investigator’s financial interests in the study drug were varied.
Willingness to participate was less if the investigator had equity in
the drug company than for per capita payments to the investiga-
tor’s research organisation (P = 0.01), or if there was no disclosure
(P = 0.03). A second study, Weinfurt 2008b, had five scenarios
presenting various financial interests and found that the various
disclosures did not substantially affect participants’ willingness to
take part in the hypothetical asthma or diabetes trial.
Karunaratne 2010 compared an interactive computer presentation
of information about a hypothetical trial onmanaging heart attack
complications with standard paper-based information and found
that this may not lead to any difference in recruitment (Analysis
34.1). Llewellyn-Thomas 1995b found that an interactive com-
puter presentation of trial information probably slightly improved
recruitment to a hypothetical cancer trial compared to an audio-
tape presentation (Analysis 35.1).
Simel 1991 used two different consent forms for a hypothetical
trial of a new medication, one saying the new treatment may work
‘twice as fast’, the other saying the new treatment may work ‘half
as fast’, as standard care. Both consent forms were read aloud to
potential participants. The first consent form probably improved
recruitment (RR 1.62, 95% CI 1.10 to 2.37) although it is not
clear how applicable this result is to real trials (Analysis 36.1).
Simes 1986 compared provision of total disclosure of a range of
information relevant to a cancer trial versus more limited default
disclosure with additional provision being at the discretion of the
clinician. The intervention led to little or no difference in recruit-
ment (Analysis 37.1). Kerr 2004 considered the impact of describ-
ing treatments as new or standard in patient information leaflets
for a hypothetical arthritis trial. Describing a treatment as new
may slightly decrease recruitment (Analysis 38.1).
Miller 1999 evaluated the cost-effectiveness of screening for clini-
cal trials by senior investigators compared to research assistants but
did present effect on recruitment as a secondary outcome. These
authors found that screening by senior investigators may not lead
to any difference in recruitment (Analysis 39.1).
Kimmick 2005 ran a cluster trial involving 126 oncology cen-
tres to compare the effect of an educational intervention aimed
at improving recruitment of older participants at cancer centres
that were part of a network of cancer centres. Although the au-
thors did not present centre-level recruitment data, or provide an
intracluster correlation coefficient, they did consider intracluster
correlation in their analysis. An educational package comprising
standard information plus a symposium, additional educational
materials, monthly mailings and emails for one year, lists of trial
protocols to attach to patient charts and a seminar did not sig-
nificantly increase recruitment compared to standard information
alone (31% of participants aged over 65 in both intervention and
control groups in year 2, P = 0.83).
Financial incentives for participants
Three studies involving 888 participants evaluated the effect of
financial incentives on trial recruitment; one involved a real trial,
two hypothetical trials. Free 2010 sent a GBP £5 note together
with a letter containing study and consent information in a smok-
ing cessation trial, which improved recruitment (RR 12.95, 95%
CI 1.71 to 98.21) (Analysis 40.1).
Bentley 2004 investigated the effect of three levels of risk presen-
tation (high, medium and low) and three levels of financial in-
centive (USD $1800, $800 and $350), giving nine interventions
in total, on willingness to take part in a hypothetical trial. The
number of individuals willing to participate is not given in the
published report for the study but financial incentives increased
willingness to participate for all three risk levels (P = 0.015). For
a fixed risk, willingness to participate increased with the size of
the financial incentive for each of the three risk levels. Halpern
2004 did something similar by varying risk (either adverse events
or rate of randomisation to placebo) and incentives (USD $2000,
$1000 and $100) for a hypothetical trial of an antihypertensive
drug. Willingness to participate increased as payment rose (P <
0.001).
Modification to the training given to recruiters
One study with 96 recruiters (Larkey 2002) evaluated the effect
of using trained Hispanic women already taking part in a trial as
lay advocates to refer women to trials within the Women’s Health
Initiative. The training comprised six hours of training in informal
sessions and concentrated on the communication of benefits to
Latinas of being in the trial. The authors did not report an analysis
that corrected for the clustering or provide an intracluster correla-
tion coefficient. Data at the recruiter aggregate level were reported
on whether a recruiter did or did not recruit anyone to the trial.
Eight of the 28 trained Hispanic recruiters recruited one or more
women to the trial whereas none of the 26 untrained Hispanic
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women recruited anyone the trial. Two of the 42 untrained Anglo
control group recruited two women.
Greater contact between trial co-ordinator and trial sites
Two studies investigated the effect of greater contact between trial
co-ordinators and trial sites in multicentre cluster trials. Liénard
2006 (135 trial sites) evaluated onsite initiation visits to review the
trial protocol, inclusion and exclusion criteria, safety, randomisa-
tion and other trial aspects in a multicentre breast cancer trial.
They did not provide sufficient data to allow for an analysis which
adjusted for clustering. The authors did not present the propor-
tion of eligible participants recruited, only the number recruited:
visited sites recruited 302 participants while those not receiving
visits recruited 271. The difference was reported to be not statis-
tically significant (no P value was given). Monaghan 2007 (167
trial sites) evaluated the effect of additional communication strate-
gies (e.g. individually-tailored feedback on recruitment) with trial
sites. The authors did not present the proportion of eligible partic-
ipants recruited. Site level analyses of the time to meet half of the
site’s recruitment target and the median number recruited were
reported. The median total number of participants in the addi-
tional communication group was 37.5, compared to 37.0 in the
standard communication group. This difference was not statisti-
cally significant (P = 0.68). Intervention centres achieved half their
recruitment targets in 4.4 months, compared to 5.8 months for
control centres. This difference was not statistically significant (P
= 0.08).
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Open RCT versus blinded RCT
Patient or population: Individuals eligible for a trial
Settings: Any
Intervention: Open RCT
Comparison: Blinded RCT
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Blinded RCT Open RCT
Number recruited Low1 RR 1.22
(1.09 to 1.36)
4833
(2 studies)
⊕⊕⊕©
moderate2
30 per 100 37 per 100
(33 to 41)
Moderate1
50 per 100 61 per 100
(55 to 68)
High1
70 per 100 85 per 100
(76 to 95)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 The low, moderate and high illustrative recruitment levels of 30%, 50% and 70% were selected based on our prior experience with trial
recruitment.
2 There was moderate heterogeneity, I2 = 64%.
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Consent to experimental care versus usual consent
Patient or population: Individuals eligible for trial
Settings: Any
Intervention: Consent to experimental care
Comparison: Usual consent
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Usual consent Consent to experimental
care
Willingness to partici-
pate
Low1 RR 1.01
(0.98 to 1.05)
2456
(2 studies)
⊕⊕©©
low2
30 per 100 30 per 100
(29 to 31)
Moderate1
50 per 100 50 per 100
(49 to 52)
High1
70 per 100 71 per 100
(69 to 73)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 The low, moderate and high illustrative recruitment levels of 30%, 50% and 70% were selected based on our prior experience with trial
recruitment.
2 Risk of bias: Myles 1999 = B, Perrone 1995 = C. Categorised as moderate to high risk of bias overall.
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Consent to standard care versus usual consent
Patient or population: Individuals eligible for trial
Settings: Any
Intervention: Consent to standard care
Comparison: Usual consent
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Usual consent Consent to standard care
Willingness to partici-
pate
Low1 RR 0.76
(0.49 to 1.17)
1759
(2 studies)
⊕©©©
very low2,3
30 per 100 23 per 100
(15 to 35)
Moderate1
50 per 100 38 per 100
(25 to 58)
High1
70 per 100 53 per 100
(34 to 82)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.1
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Very low quality: We are very uncertain about the estimate.
1 The low, moderate and high illustrative recruitment levels of 30%, 50% and 70% were selected based on our prior experience with trial
recruitment.
2 Risk of bias: Myles 1999 = B, Perrone 1995 = C. Categorised as moderate to high risk of bias overall.
3 There was substantial heterogeneity, I2 = 93%. Perrone 1995 found in favour of the control, while Myles 1995 found little or no
difference between intervention and control.
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Educational audiovisual information versus standard information
Patient or population: Individuals eligible for trial
Settings: Any
Intervention: Educational audiovisual information
Comparison: Standard information
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Standard information Educational audiovisual
information
Number recruited Low1 RR 1.20
(0.75 to 1.91)
495
(3 studies)
⊕©©©
very low2,3,4
30 per 100 36 per 100
(22 to 57)
Moderate1
50 per 100 60 per 100
(38 to 95)
High1
70 per 100 84 per 100
(52 to 100)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 The low, moderate and high illustrative recruitment levels of 30%, 50% and 70% were selected based on our prior experience with trial
recruitment.
2 Du 2008 = moderate risk of bias (B), Du 2009 = high risk of bias, Hutchison 2007 = low risk of bias. Categorised as moderate risk
of bias overall.
3 All three studies suggest little or no difference in recruitment due to the intervention but the Hutchison 2007 point estimate was in
favour of control, while that of both Du studies was in favour of the intervention.
4 The confidence limits for all three studies were wide, especially the two Du studies, and all three included the possibility of benefit or
harm.
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Study-related questionnaire + trial invitation versus trial invitation
Patient or population: Individuals eligible for a trial
Settings: Any
Intervention: Study-related questionnaire + trial invitation
Comparison: Trial invitation
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Trial invitation Study-related question-
naire + trial invitation
Number recruited Low1 OR 1.17
(0.74 to 1.87)
2673
(2 studies)
⊕⊕⊕©
moderate2
30 per 100 33 per 100
(24 to 44)
Moderate1
50 per 100 54 per 100
(43 to 65)
High1
70 per 100 73 per 100
(63 to 81)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; OR: Odds ratio;
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 The low, moderate and high illustrative recruitment levels of 30%, 50% and 70% were selected based on our prior experience with trial
recruitment.
2 Harris 2008 found that the intervention had little or no effect on recruitment, while Kendrick 2001 found that the intervention improved
recruitment.
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Clinical trial booklet + standard information versus standard information
Patient or population: Individuals eligible for trial
Settings: Any
Intervention: Clinical trial booklet + standard information
Comparison: Standard information
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Standard information Clinical trial booklet +
standard information
Willingness to partici-
pate/number recruited
Low1 RR 1.11
(0.71 to 1.72)
91
(2 studies)
⊕©©©
very low2,3,4
30 per 100 33 per 100
(21 to 52)
Moderate1
50 per 100 56 per 100
(35 to 86)
High1
70 per 100 78 per 100
(50 to 100)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 The low, moderate and high illustrative recruitment levels of 30%, 50% and 70% were selected based on our prior experience with trial
recruitment.
2 Risk of bias: Ives 2001 = C, Ellis 2002 = C. Categorised as high risk of bias overall.
3 There was some heterogeneity, I2 = 46% but this was not judged sufficient to categorise as serious inconsistency.
4 Ellis 2002 involved a hypothetical trial so the outcome was willingness to participate, not actual participation.
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D I S C U S S I O N
This review identified 45 studies, 18 new to this update, that evalu-
ated the effect of six categories of strategies to improve recruitment
to randomised controlled trials. The interventions used in these
studies varied significantly, which made it difficult to pool data.
Even those studies based on the same basic strategy (e.g. changing
the consent process) were generally sufficiently different to make
pooling inappropriate (Engels 2000). For example, although there
were five studies and seven interventions looking at changes to
consent procedures, only two interventions were similar enough to
be pooled. Videos were used in six studies but generally delivered
different information, or were used in combination with other
interventions that differed between studies. Only three could be
combined in the same analysis. We had planned to investigate the
impact of recruiting to a hypothetical trial versus a real trial but
were unable to due to the lack of studies. For only one comparison
was there at least one of each kind of trial and we were therefore
unable to assess this factor. Only one of the cluster trials (Harris
2008) provided sufficient data to allow an appropriate analysis to
be incorporated in the review. Additionally there were a number of
studies which potentially had data clustered by the study the par-
ticipant was invited to join (e.g. Hutchison 2007 and Kerr 2004)
even though the participants were individually randomised and
estimates from these studies may be overly precise.
While new studies were added to the review, the overall picture
with regard to interventions to improve recruitment to trials re-
mains similar to the previous version of the review. Most studies
did not provide clear evidence of benefit. Many studies were small,
likely to be underpowered and with confidence intervals including
the possibility of substantial benefit. This is particularly true of
interventions that modified the approach made to potential par-
ticipants by, for example, presenting trial information to them in
different ways. Moreover, 19 studies involved hypothetical trials
and it is not clear how applicable their results are to real trials. Our
suggestion to trialists is to build evaluations of recruitment inter-
ventions into their real trials rather than use hypothetical trials.
Additionally, we had hoped to be able to do a number of subgroup
analyses but the variations in the interventions themselves would
have made these comparisons meaningless.
Some interventions do appear to be effective, although the evi-
dence base for some is still rather small. Telephone reminders to
non-responders (Harris 2008; Nystuen 2004), opt-out procedures
requiring potential participants to contact the trial team if they did
not want to be contacted about a trial (Trevena 2006), including
GBP £5 together with the trial invitation (Free 2010) and mak-
ing the trial open rather than blinded (Avenell 2004; Hemminki
2004) all improved recruitment in high-quality studies involving
real trials. There are, however, caveats. For telephone reminders,
the pooled analysis has moderate heterogeneity (I2 = 59%) though
it would seem that it is the magnitude of effect and not the ben-
efit of telephone reminders that is in doubt. Although the GBP
£5 financial incentive used in Free 2010 improved recruitment,
the total number of participants recruited was very small, lead-
ing to substantial uncertainty about the magnitude of the benefit.
Two other studies involving financial incentives (Bentley 2004;
Halpern 2004) found that increasing payment led to increased re-
cruitment but this was to hypothetical trials using sums of money
that may not be feasible in real trials. Both telephone reminders
and financial incentives are promising but would benefit from ad-
ditional, rigorous evaluation. Ethical concerns have been raised
about their use (i.e. that they amount to a formof coercion) though
both have been used and are accepted by many. Opt-out has been
proposed by others (e.g. Hewison 2006) as a way of improving
recruitment to health research but it remains controversial because
ethics committees generally require that research participants give
their active, opt-in approval to research participation, including
being contacted about the research by researchers. However, it is
worth noting that Trevena 2006 studied opting-out of being con-
tacted about a trial and not opting-out of consenting to actually
take part in the trial. This is perhaps less controversial and ethics
committees may be more willing to accept this as part of a recruit-
ment strategy. While it may be easier to recruit to an open trial,
there is clearly a greater risk of bias with such trials over blinded
trials.
The effect of other strategies to improve recruitment to trials re-
mains less clear. Partial preference designs may improve recruit-
ment to a study as a whole but not to the randomised part (Cooper
1997). Other than the opt-out strategy mentioned above, a whole
range of strategies involving changes to consent procedures failed
to produce promising recruitment strategies. Modifications to the
way or quantity of information presented to potential participants
about trials in general, or about one trial in particular, did not
provide clear evidence in favour of this approach to improving re-
cruitment. Providing potential participants with quotes from ex-
isting participants via SMS (Free 2010) looks promising but re-
quires further evaluation. Three studies looked at strategies aimed
not at potential participants but at those recruiting them (Larkey
2002; Liénard 2006; Monaghan 2007) and none presented clear
evidence in favour of the strategies used.
Potential bias was a problem in many of the included studies.
Although allocation concealment was considered high quality for
23 of the 45 studies (it was unclear for 15 and poor for seven), the
overall assessment of the risk of bias was considered as low for only
12 studies. Twenty studies were considered to be at high risk of
bias. Thiswas often linked tohypothetical trials. It was not possible
to predict the direction of effect that any bias may have had on
study outcomes. We were unable to make statistical judgements
about the likelihood of publication and related biases with our
relatively small number of included studies per comparison and
the wide variation in the recruitment strategies being evaluated.
Four potentially eligible studies identified by our search were not
included in this review because the reference returned by the search
was incomplete or incorrect. We will aim to obtain sufficient in-
27Strategies to improve recruitment to randomised controlled trials (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
formation to include or exclude these studies when we update this
review. We would welcome feedback about studies that have been
missed or newly published studies.
A U T H O R S ’ C O N C L U S I O N S
Implication for systematic reviews and
evaluations of healthcare
Some interventions to increase recruitment do appear to be ef-
fective: telephone reminders to non-respondents; use of opt-out,
rather than opt-in procedures for contacting potential trial partic-
ipants; and open designs. The use of open trial designs needs to
be considered carefully since the lack of blinding may lead to bias.
Financial incentives look promising but would benefit from more
evaluation. Evidence is inconclusive for several interventions, in-
cluding the use of video to provide information to potential par-
ticipants and some types of change to consent procedures. There
is evidence to suggest that preference designs, the use of a placebo
as a comparator, and greater contact between trial co-ordinators
and recruiting sites may not increase recruitment.
Implication for methodological research
Trialists should include evaluations of their recruitment strategies
in their trials and funders should support this because the number
of interventions that have been rigorously evaluated in the context
of a real trial is low. The use of hypothetical trials to study recruit-
ment strategies has its place but it would be better if methodol-
ogists could collaborate with trialists to study recruitment in real
trials. Two interventions, financial interventions and SMS mes-
sages to potential participants, are clearly worth further evaluation.
There is a clear gap in knowledge with regard to effective strategies
aimed at recruiters and research into how to increase recruitment
by sites participating in trials would be beneficial.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Avenell 2004
Methods Randomised controlled trial
Data Setting: secondary care, UK. Participants were patients aged 70 or over attending a fracture clinic or
orthopaedic ward. 538 participants
Comparisons Investigated the effect of different trial designs
Open trial design comparing vitamin D, versus calcium, versus vitamin D and calcium, versus no tablets.
Compared to conventional trial comparing vitamin D, versus calcium, versus vitamin D and calcium,
versus placebo
Outcomes Proportion recruited to trial.
Notes Overall risk of bias - A: Low risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Yes Blinding only partial but looking at the effect of open study design was
the purpose of the study
Objective outcomes? Yes Proportion recruited to trial
Bentley 2004
Methods Randomised controlled trial
Data Setting: university, USA. Participants were pharmacy students. 270 participants
Comparisons Investigated the effect of financial incentives and trial risk
Nine-arm trial looking at the effect of financial incentives and bonus based on the level of risk (high,
medium or low) associated with the intervention drug
Interventions A-C: information on high-risk trial for a drug not yet tested on humans, paying one of USD
$1800, $800 or $350
Interventions D-F: information on medium-risk study for a generic drug already on the market, paying
one of USD $1800, $800 or $350
Intervention G-I: information on low-risk study measuring salivary levels of stress hormones, paying one
of USD $1800, $800 or $350
Outcomes Willingness to take part in hypothetical studies
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Bentley 2004 (Continued)
Notes Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Unclear Participants potentially able to discuss, though people handing out en-
velopes (course instructors) blinded
Objective outcomes? No Hypothetical trial
Cooper 1997
Methods Randomised controlled trial
Data Setting: secondary care, UK. First time attendees at a gynaecological clinic. 273 participants
Comparisons Investigated the effect of different trial designs
Partially randomised patient preference design allocating tomedicalmanagement or transcervical resection
of the endometrium or preferred option. Comparator was a conventional trial design allocating to medical
management or transcervical resection of the endometrium
Outcomes Proportion recruited to trial
Notes Overall risk of bias - A: Low risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Yes Participants were blinded but not investigators
Objective outcomes? Yes Proportion recruited to trial
Coyne 2003
Methods Randomised controlled trial
Data Setting: secondary care, USA. Patients eligible for participation in a cancer treatment trial. 226 participants
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Coyne 2003 (Continued)
Comparisons Investigated the effect of different consent methods
Easy to read consent statements (altered text style, layout, font size, vocabulary; reading level 7th to 8th
grade) were compared to standard consent statements
Outcomes Proportion recruited to trial
Notes Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear No details given
Blinding? Unclear Nurse clearly knew that the participant had intervention or control consent
statement; not clear howmuch participant was told about the intervention.
Not clear if telephone interviewers knew the allocation
Objective outcomes? Yes Proportion recruited to trial
Diguiseppi 2006
Methods Quasi-randomised controlled trial
Data Setting: health maintenance organisation, USA. Participants were patients aged 18 or over attending the
HMO with an acute injury. 469 participants
Comparisons Investigated the effect of different methods of pre-screening participants
Telephone administered questionnaire on hazardous drinking and willingness to participate in lifestyle
intervention. This was compared to face-to-face administered questionnaire on hazardous drinking and
willingness to participate in lifestyle intervention
Outcomes Proportion recruited to hypothetical trial
Notes Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No By week
Blinding? Unclear Potential participants were probably blind but researchers and prac-
tice staff were not blind
Objective outcomes? No Hypothetical trial
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Du 2008
Methods Randomised controlled trial
Data Setting: secondary care, USA. Patients aged 21 to 80 attending multidisciplinary lung clinic at a cancer
centre. 126 participants
Comparisons Investigated the effect of different methods of providing information about the trial
18-minute educational video giving an overview of clinical trials and the importance of cancer clinical
research to society. This was compared to standard care (i.e. normal first visit to oncologist)
Outcomes Proportion recruited to trial
Notes Overall risk of bias - B: Moderate risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear No details given
Blinding? Yes Oncologist was blinded but the participant was not (not clear if they were
told that intervention was a video versus standard care)
Objective outcomes? Yes Proportion recruited to trial
Du 2009
Methods Randomised controlled trial
Data Setting: secondary care, USA. Women scheduled for treatment evaluation by medical oncology specialist
at KCI breast clinic. Aged 21 to 80, new female patient at clinic, with diagnosis of histologically confirmed
invasive breast cancer, and self-determined as white or African America. Plus (a) the ability to read and
understand English at least at the 6th grade level, (b) the capability to make their own treatment decisions,
(c) not having previously participated in a cancer clinical trial, and (d) performance status (PS) B 2
(Southwest Oncology Group (SWOG) scale). 196 participants
Comparisons Intervention: 18-minute video. The video presents an overview of Phase I, II and III clinical trials and the
importance of cancer clinical research to society. The video addresses common concerns regarding clinical
trials and cancer treatment from the patient’s perspective such as side effects, expected risks and benefits,
eligibility criteria, the enrolment process, and treatment costs.
Comparator: usual practice - return to waiting room but not clear what ‘standard care’ actually is
Outcomes Enrolment in therapeutic trials
Notes Overall risk of bias - C: High risk of bias
Risk of bias
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Du 2009 (Continued)
Item Authors’ judgement Description
Allocation concealment? Unclear No details given
Blinding? Unclear Not clear if staff were blinded and for participants it depended on what
they had been told about study. Participants completed questionnaire’s
themselves so may not have been influenced by staff if staff were unblinded
Objective outcomes? Yes Enrolment in therapeutic trials
Ellis 2002
Methods Randomised controlled trial
Data Setting: secondary care, Australia. Women undergoing definitive surgical operation for early stage breast
cancer. 60 participants
Comparisons Intervention: Booklet explaining trials, how treatment is selected in RCT, discussion of treatment options,
examples of trials, where to get more info, advantages and disadvantages of participating + usual informa-
tion from clinician, discussion of treatment which may include discussion of RCT, no standardisation of
what is discussed
Comparator: Usual information from clinician, discussion of treatment which may include discussion of
RCT, no standardisation of what is discussed
Outcomes Willingness to take part in hypothetical trial
Notes Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear Text says ’randomised centrally’ but not clear what this means
Blinding? Unclear Not clear what participants were told. Not clear if clinicians providing
general advice knew allocation
Objective outcomes? No Hypothetical trial
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Ford 2004
Methods Randomised controlled trial
Data Setting: community, USA. African American men aged 55 to 74 eligible for a prostate, lung and colorectal
cancer screening trial. 12,400 participants
Comparisons Investigated the effect of different trial information and consent methods
Intervention A: Enhanced recruitment letter, telephone call by African American interviewer, baseline
information by mail, reminder calls/mailings for baseline information/consent
Intervention B: Enhanced recruitment letter, telephone call by African American interviewer, baseline
information over telephone, reminder calls/mailings for consent form
Intervention C: Enhanced recruitment letter, telephone call by African American interviewer, church
session, baseline information at church session
Compared to standard recruitment letter, telephone assessment by African American or Caucasian inter-
viewer, baseline information by mail, reminder calls/mailings for baseline information/consent
Outcomes Proportion recruited to trial
Notes Overall risk of bias - B: Moderate risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear No details given
Blinding? Unclear Potential participants were blinded but the researchers probably were not
blinded
Objective outcomes? Yes Proportion recruited to trial
Fowell 2006
Methods Randomised controlled trial
Data Setting: secondary care, UK. Cancer inpatients receiving palliative care and starting on a syringe driver.
53 participants
Comparisons Investigated the effect of different trial designs
Cluster randomisation compared to Zelen’s design (in which only those randomised to the intervention
group were asked for consent)
Outcomes Proportion recruited to trial
Notes Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
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Fowell 2006 (Continued)
Allocation concealment? Unclear No details given
Blinding? Yes Blinding only partial but looking at the effect of open study design was
the purpose of the study
Objective outcomes? Yes Proportion recruited to trial
Free 2010
Methods Randomised controlled trial
Data Setting: Community, UK. Participants were daily smokers, 16 or over, wanting to stop smoking in next
month. 1302 participants
Comparisons Investigated whether including GBP £5 with invitation increased recruitment and does sending SMS
messages to potential participants increase recruitment?
Intervention A: GBP £5 with participant info sheet and consent form
Intervention B: series of 4 text messages with quotes from existing participants
Comparator: normal trial procedures - letter with participant information sheet and consent form
Outcomes Proportion recruited to trial
Notes Overall risk of bias - A: Low risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Yes Those assessing outcomes were blinded
Objective outcomes? Yes Proportion recruited to trial
Freer 2009
Methods Randomised controlled trial
Data Setting: secondary care, UK. Participants were parents of immature infant(s) were admitted to a large
tertiary NICU but which did not require intensive care (i.e. not requiring mechanical ventilation or
continuous observation). 41 participants
Comparisons Intervention A: US trial leaflet with explanation
Intervention B: US trial leaflet alone
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Freer 2009 (Continued)
Intervention C: UK trial leaflet with explanation
Intervention D: UK trial leaflet alone
Outcomes Willingness to take part in a hypothetical study
Notes Overall risk of bias - B: Moderate risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Unclear Depends what researchers providing standard statements knew and what
participants were told about the study
Objective outcomes? No Hypothetical trial
Fureman 1997
Methods Randomised controlled trial
Data Setting: university, USA. Participants in the Risk Assessment Project (injection drug users). 188 partici-
pants
Comparisons Investigated the effect of different trial information methods
Enhanced video on anHIVvaccine trial plus 1-hour pamphlet presentation (5minutes pre-test, 26minutes
of video, 10 minutes to review pamphlet, research assistant initiated question and answer session, post-test
questionnaire, survey at 1 month. This was compared to standard half-hour pamphlet-only presentation
(5 minutes pre-test, 10 minutes to review trial information pamphlet, research assistant initiated question
and answer session, post-test questionnaire, survey at 1 month
Outcomes Willingness to take part in hypothetical trial (expressed as a score on a willingness scale)
Notes Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear No details given
Blinding? Unclear Not clear how much participants were told before the study, not clear
what the research assistant running sessions knew about randomisation;
probably knew that video was the intervention. Assistant could in principle
influence post-test questionnaire responses of participants because these
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Fureman 1997 (Continued)
were done during the session
Objective outcomes? No Hypothetical trial
Graham 2007
Methods Quasi-randomised controlled trial
Data Setting: health maintenance organisation, USA. Participants were patients aged 18 or over attending the
HMO with an acute injury. 370 participants
Comparisons Investigated the effect of different methods of pre-screening participants
Intervention A: Electronic questionnaire on hazardous drinking and willingness to participate in lifestyle
intervention
Intervention B: Oral questionnaire read aloud to patients in the clinic, potential answers printed on cards
and patients asked to point
Compared to standard self complete paper questionnaire
Outcomes Willingness to take part in a hypothetical trial
Notes Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No By week
Blinding? Yes Potential participants probably blind but not researchers or practice
staff
Objective outcomes? No Hypothetical trial
Halpern 2004
Methods Randomised controlled trial
Data Setting: secondary care, USA. Participants who had mild to moderate hypertension and whomet standard
entry criteria (unclear what these are) for phase 2 and 3 trials at the clinic), attending clinic on selected
interview days. Exclusion criteria were unable/unwilling to give oral informed consent and any exclusion
criteria for the current Phase 3 trials at the clinic (it was unclear what these were). 126 participants
Comparisons Intervention A: The variables altered were (1) information regarding the percentage of previous patients
who experienced adverse effects from the study drug (10%, 20% and 30%) and (2) the payment partici-
pants would receive (USD $100, $1000, and $2000)
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Halpern 2004 (Continued)
Intervention B: the variables altered were (1) the percentage of patients who would be assigned to placebo
(10%, 30% and 50%) and (2) the payment level
Outcomes Willingness to participate in a hypothetical trial (patients were told the trial was real but then told trial
was not but after decision, so still not a real decision)
Notes Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No Participants were selected on alternate days of the week
Blinding? No Participants blind but not investigator who could, in principle, influence
their responses because data collection was via interview
Objective outcomes? No Hypothetical trial
Harris 2008
Methods Cluster-randomised controlled trial
Data Setting: community, UK. Participants were aged≥ 65 years, able to walk outside the home and registered
with a 6-partner general practice (primary health care centre). Those living in care homes, those with
dementia, terminal illness, poorly controlled cardiac failure or unstable angina and those housebound
due to disability were excluded by computer record search and by general practitioner and district nurse
examination of patient lists. Patients undergoing active follow-up in another research study at the practice
(investigating the effect of fish oils on cognitive function) were also excluded. 560 participants
Comparisons Intervention A: Personalised letter + info sheet
Intervention B: Personalised letter + info sheet + 12-page questionnaire asking about physical health,
mood, ability to perform daily activities etc.
Intervention C: Personalised letter + info sheet +telephone reminders (up to 4)
Intervention D: Personalised letter + info sheet + 12-page questionnaire asking about physical health,
mood, ability to perform daily activities etc + telephone reminders (up to 4)
Outcomes Proportion recruited to trial
Notes Overall risk of bias - A: Low risk of bias. Clustering was accounted for in analysis
Risk of bias
Item Authors’ judgement Description
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Harris 2008 (Continued)
Allocation concealment? Yes Adequate
Blinding? Yes Participants were blinded. Research nurse was not.
Objective outcomes? Yes Proportion recruited to trial
Hemminki 2004
Methods Randomised controlled trial
Data Setting: ’local clinics’, Estonia. Postmenopausal women aged 50 to 64. 4295 participants
Comparisons Investigated the effect of different design methods
Non-blinded allocation comparing active HRT treatment versus no treatment. This was compared to
traditional blinded allocation comparing active HRT treatment versus placebo
Outcomes Proportion recruited to trial
Notes Overall risk of bias - A: Low risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Yes Blinding only partial but looking at the effect of open study design was
the purpose of the study
Objective outcomes? Yes Proportion recruited to trial
Hutchison 2007
Methods Randomised controlled trial
Data Setting: secondary care, UK. Patients with colorectal, breast, lung cancer and clinically eligible to enter
one of centre’s trials; access to a video recorder, CD-ROM or DVD player; can understand English. 173
participants
Comparisons Intervention: Video covering general trial info, randomisation, pictures of patients receiving care +
voiceover discussing uncertainty + standard practice (clinician discussing treatment options and possibility
of taking part in a trial) + standard practice
Comparator: Standard practice (clinician discussing treatment options and possibility of taking part in a
trial)
Outcomes Proportion recruited to trial
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Hutchison 2007 (Continued)
Notes Overall risk of bias - A: Low risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Unclear Not clear if patients know about video versus normal info when consent-
ing. Staff may also be unblinded although materials are sent to them at
home and all participants receive standard care so probably small chance
of introducing bias
Objective outcomes? Yes Proportion recruited to trial
Ives 2001
Methods Randomised controlled trial
Data Setting: secondary care, UK. Patients attending an HIV hospital clinic. 50 participants
Comparisons Investigated the effect of different trial information methods
Standard trial information plus booklet entitled, “Clinical Trials inHIV and AIDS: Information for people
who are thinking about joining a trial”. This was compared to standard trial information (information
sheet specific to proposed trial, plus discussion with trial doctor and research nurse)
Outcomes Proportion recruited to trial
Notes Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? No Patients and investigators not blinded
Objective outcomes? Yes Proportion recruited to trial
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Jeste 2009
Methods Randomised controlled trial
Data Setting: secondary care, USA. Participants were > 40 years, with schizophrenia, fluency in English and
an absence of a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), 34
diagnosis of current substance use disorder, dementia or other known conditions likely to influence
decisional capacity independent of the effects of schizophrenia and/or by verbal report from the patients’
treating clinicians. 128 participants
Comparisons Intervention: DVD presenting key information from consent form plus a narrator explaining consent
relevant info, video and slides as well. A Research Assistant also was there to answer questions.
Comparator: Printed consent information plus a 10-minute control DVD giving general info about
research. A Research Assistant also was there to answer questions
Outcomes Willingness to participate in a hypothetical trial
Notes Overall risk of bias - B: Moderate risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Yes Researchers were blind but not clear how much participants knew about
aim of study. They probably were blind
Objective outcomes? No Hypothetical trial
Karunaratne 2010
Methods Randomised controlled trial
Data Setting: secondary care, Australia. Participants were English speaking, computer-literate patients with
diabetes aged 18 to 70, able to travel to hospital. 60 participants
Comparisons Intervention: Computer-based presentation of information on leaflet but with interactive explanatory
features, e.g. text linked to keywords, video clips
Comparator: Paper-based information
Outcomes Willingness to take part in a hypothetical trial
Notes Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
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Karunaratne 2010 (Continued)
Allocation concealment? Unclear No details given
Blinding? Unclear Unclear if participants knew nature of the intervention when consenting.
Not clear if staff doing one-to-one interviews were blinded
Objective outcomes? No Hypothetical trial
Kendrick 2001
Methods Randomised controlled trial
Data Setting: primary care, UK. Families with children aged under 5 years, living in deprived areas. 2393
participants
Comparisons Investigated the effect of different trial information methods
Mailed invitation to participate in an injury prevention trial, including a home safety questionnaire. This
was compared to mailed invitation to participate excluding the home safety questionnaire
Outcomes Proportion recruited to trial
Notes Overall risk of bias - A: Low risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Yes Participants blinded, but researchers know (probably). However, because
mailed questionnaire no way researchers could influence result
Objective outcomes? Yes Proportion recruited to trial
Kerr 2004
Methods Randomised controlled trial
Data Setting: Further Education colleges, UK. Participants were 18+ and enrolled on further education and
leisure courses. 130 participants
Comparisons Investigated the effect of describing trial treatments as new or standard for two disease areas, arthritis and
back pain
Intervention A: arthritis: treatment A described as standard, treatment B described as standard
Intervention B: arthritis: treatment A described as new, treatment B described as standard
Intervention C: arthritis: treatment A described as new, treatment B described as new
Intervention D: back pain: treatment A described as standard, treatment B described as standard
Intervention E: back pain: treatment A described as new, treatment B described as standard
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Kerr 2004 (Continued)
Intervention F: back pain: treatment A described as new, treatment B described as new
Outcomes Willingness to participate in a hypothetical trial
Notes Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No Although starting point was selected randomly, from then on there is
no concealment because the scenarios were ordered consecutively from a
starting point
Blinding? Unclear Students were probably blind but not clear about staff
Objective outcomes? No Hypothetical trial
Kimmick 2005
Methods Cluster-randomised controlled trial
Data Setting: secondary care and academic institutions, USA. Practitioners and researchers from Cancer and
Leukaemia Group B (CALGB) institutions. 126 centres
Comparisons Investigated the effect of different trial information methods
Educational intervention of standard information plus an educational symposium, geriatric oncology
educational materials, monthlymailings and e-mails for 1 year, lists of available protocols for use on patient
charts, case discussion seminar. This was compared to standard information of periodic notification of all
existing CALGB trials by the CALGB Central Office, and CALGB web site access
Outcomes Proportion recruited to trial
Notes Overall risk of bias - C: High risk of bias. Clustering was accounted for in the analysis
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear No details given
Blinding? Unclear Not clear what details were given to the participants about the study
before it started
Objective outcomes? Yes Proportion recruited to trial
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Larkey 2002
Methods Cluster-randomised controlled trial
Data Setting: various existing trial sites, USA. Participants in theWomen’s Health Initiative trial. 96 participants
Comparisons Investigated the effect of different methods of training lay advocates for trials
Intervention A: Hispanic lay advocates; attended 6 hour-long training sessions, 5 quarterly meetings and
received brochures with interest cards to distribute to other women
Intervention B: Hispanic women controls, received quarterly telephone calls and brochures with interest
cards to distribute to other women
Compared to Anglo women controls, received quarterly telephone calls and brochures with interest cards
to distribute to other women
Outcomes Proportion recruited to trial
Notes Overall risk of bias - B: Moderate risk of bias. Clustering was not accounted for in the analysis
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear No details given
Blinding? Unclear Not clear if the participants were blinded
Objective outcomes? Yes Proportion recruited to trial
Litchfield 2005
Methods Cluster-randomised controlled trial
Data Setting: primary care, UK. Participants were general practices participating in a trial of 2 delivery systems
for insulin, NovoPen and Innovo. 28 practices were involved, which recruited 73 participants
Comparisons Intervention: electronic data capture
Comparator: paper data capture
Outcomes Number of participants recruited to the trial. Improving recruitment was not the main aim (improving
efficiency was the main aim) of the study though this information is provided
Notes Overall risk of bias - B: Moderate risk of bias. Clustering was not accounted for in analysis
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
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Litchfield 2005 (Continued)
Blinding? Unclear Investigators knew that both paper and electronic data collection
were to be used so study was not blinded. Unlikely that patient
decisions to join study would be affected by this. Not clear how
much influence knowledge of data collection method might have
had on practices
Objective outcomes? Yes Number of participants recruited to the trial. Improving recruit-
ment was not the main aim (improving efficiency was the main
aim) of the study though this information is provided
Liénard 2006
Methods Cluster-randomised controlled trial
Data Setting: secondary care, France. Centres recruiting to a randomised controlled trial for breast cancer. 573
participants
Comparisons Investigated the effect of organising visits by the trial co-ordination team to centres participating in a
multicentre trial
Site visits including an initiation visit to review trial protocol, inclusion/exclusion criteria, safety, ran-
domisation etc. plus ongoing review visits. This was compared to no site visits (unless requested)
Outcomes Proportion recruited to trial
Notes Overall risk of bias - A: Low risk of bias. Clustering was not accounted for in the analysis
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Yes Centres blind. Somewhat unclear if monitors were blind but prob-
ably were not
Objective outcomes? Yes Proportion recruited to trial
Llewellyn-Thomas 1995a
Methods Randomised controlled trial
Data Setting: secondary care, Canada. Colorectal cancer patients attending cancer hospital as outpatients. 90
participants
Comparisons Investigated the effect of different trial information methods
Intervention A: Booklet with negatively-framed intervention about treatment side effects and survival
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Llewellyn-Thomas 1995a (Continued)
Intervention B: Booklet with positively-framed intervention about treatment side effects and survival
Compared to booklet with neutrally-framed intervention about treatment side effects and survival
Outcomes Proportion recruited to hypothetical trial
Notes Overall risk of bias - B: Moderate risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Yes Interviewer was blinded, but unclear about participants
Objective outcomes? No Hypothetical trial
Llewellyn-Thomas 1995b
Methods Randomised controlled trial
Data Setting: secondary care, Canada. Patients attending the outpatient department of a cancer hospital. 100
participants
Comparisons Investigated the effect of different trial information methods
Searchable computerised information on a hypothetical trial, including purpose, description of treatment
group and randomisation, possible benefits, side effects and patients’ rights. This was compared to tape-
recorded information on a hypothetical trial, including purpose, description of treatment arm and ran-
domisation, possible benefits, side effects and patients’ rights
Outcomes Proportion recruited to hypothetical trial
Notes Overall risk of bias - B: Moderate risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Unclear Unclear if the interviewer or the participants were blinded. It depends on
what the participants were told. Interviewer did not seem to do more than
help with equipment, so perhaps limited room for bias
Objective outcomes? No Hypothetical trial
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Mandelblatt 2005
Methods Randomised controlled trial
Data Setting: community cancer clinics, USA. Participants were eligible for cancer prevention trial (high risk
of breast cancer but low risk of side effects). 450 participants
Comparisons Intervention: 5 10-minute educational session about STAR cancer prevention trial following short inter-
view about prior knowledge, risk perceptions and background. Education emphasised benefits of partici-
pation, lack of financial burden and need for minority participation in trials. Also given a brochure.
Comparator: Brochure plus short background interview
Outcomes Intention/likelihood of taking part in STAR cancer prevention trial
Notes Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear No details given
Blinding? Unclear Not clear how much info participants given about intervention during
consent process
Objective outcomes? No Intention to participate, not actual participation
Miller 1999
Methods Quasi-randomised controlled trial
Data Setting: USA, secondary care, 347 participants. Participants were eligible for 1 of the 2 trials being run
through the unit: 18 to 75 years old andDSM-IV dysthymic disorder, double depression (major depression
superimposed on antecedent dysthymia), or chronic major depression. Exclusion criteria were 1) history
of psychosis, mania or hypomania, 2) comorbid substance abuse, 3) severe medical illness, 4) failed 3
adequate trials of antidepressants from 2 different classes of antidepressants in the past 3 years and 5)
failed study medication or study psychotherapy
Comparisons Investigated whether screening my research assistants was more cost-effective than by senior investigators
Intervention: screening by senior investigator
Comparator: screening by research assistant
Outcomes Proportion recruited to trials
Notes Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
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Miller 1999 (Continued)
Allocation concealment? No Alternating screening calls were given to senior investigator
Blinding? No Investigator and research assistants knew allocation
Objective outcomes? Yes Proportion recruited to trials
Monaghan 2007
Methods Cluster-randomised controlled trial
Data Setting: existing, multicentre, international trial. Clinical sites in 19 countries recruiting to a diabetes and
vascular disease treatment trial. 167 centres
Comparisons Investigated the effect of different levels of communication between the trial co-ordination team and
participating sites
Additional communication - usual plus frequent emails, regular personalised mail-outs of league tables/
graphs of performance against other sites, certificates of achievement for recruitment/other study items
(one per month). This was compared to usual communication (provided via the regional centre) plus
occasional direct communications from the co-ordinating centre in the form of generic newsletters, emails
and faxes
Outcomes Proportion recruited to trial
Notes Overall risk of bias - A: Low risk of bias. Clustering was not accounted for in analysis
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Yes Centres were blinded, but the central office was not blind
Objective outcomes? Yes Proportion recruited to trial
Myles 1999
Methods Randomised controlled trial
Data Setting: secondary care, Australia. Inpatients aged 18 or over, scheduled for elective surgery. 769 partici-
pants
Comparisons Investigated the effect of different consent methods
InterventionA: Pre-randomised to experimental drug and asked to provide consent; if no consent, standard
treatment given
InterventionB: Pre-randomised to standard drug and asked to provide consent; if no consent, experimental
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Myles 1999 (Continued)
treatment given
Intervention C: Told that the physician thinks experimental drug superior, if consent given, has 70%
chance of receiving this; if no consent, standard treatment given
Intervention D: Allowed to increase or decrease their chance of receiving the experimental drug if consent
given, and if no preference, 50% chance of receiving it; if no consent, standard treatment given
Compared to standard randomisation method (equal chance of experimental or standard drug)
Outcomes Proportion recruited to hypothetical trial
Notes Overall risk of bias - B: Moderate risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Yes Patient is blinded (they are not told the exact details of the study in the
patient information). Researchers (probably) knew the allocation
Objective outcomes? No Hypothetical trial
Nystuen 2004
Methods Randomised controlled trial
Data Setting: community, Norway. Sick-listed employees attending a participating social security office. 498
participants
Comparisons Investigated the effect of different telephone reminders
Written invitation to participate in a community-based trial followed by a telephone reminder if no
response within 2 weeks; guide used for discussion. This was compared to written invitation to participate
in a community-based trial followed by no reminder if no response within 2 weeks
Outcomes Proportion recruited to trial
Notes Overall risk of bias - A: Low risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
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Nystuen 2004 (Continued)
Blinding? Yes Participants were blinded but not the research team, although the team do
not contact the control group
Objective outcomes? Yes Proportion recruited to trial
Perrone 1995
Methods Randomised controlled trial
Data Setting: community, Italy. Members of the general public aged under 80 years, attending a scientific
exhibition. 3573 participants
Comparisons Intervention A: 1-sided informed consent (subjects refusing were given standard treatment)
Intervention B: 2-sided informed consent (subjects refusing could choose between experimental and
standard treatment)
Intervention C: randomised to experimental (subjects refusing were given standard treatment)
Intervention D: randomised to standard (subjects refusing were given experimental treatment)
Outcomes Willingness to participate in a hypothetical trial
Notes This is same trial as Gallo 1995 but Perrone 1995 includes participants under 20
Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear No details given
Blinding? Unclear Not clear what participants were told. Researchers unblinded and since
researcher asked participants for his/her views at end of test, there is the
potential for bias
Objective outcomes? No Hypothetical trial
Pighills 2009
Methods Randomised controlled trial
Data Setting: community, UK. Participants were over 70 and on a participating GP’s list. 4488 participants
Comparisons Intervention A: Newspaper article about the trial
Intervention B: More favourable newspaper article about the trial
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Pighills 2009 (Continued)
Intervention C: The original newspaper article
Comparator: No article (i.e. usual recruitment materials)
Outcomes Proportion recruited to trial
Notes Overall risk of bias - B: Moderate risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No Control and intervention were stacked alternately in packs given to GP
practice
Blinding? Yes Recipients and practice staff blinded
Objective outcomes? Yes Proportion recruited to trial
Simel 1991
Methods Randomised controlled trial
Data Setting: secondary care, USA. Patients attending an ambulatory care clinic. 100 participants
Comparisons Investigated the effect of different consent methods
Consent form including a statement that the new treatment may work twice as fast as usual treatment.
This was compared to a consent form including a statement that the new treatment may work half as fast
as usual treatment
Outcomes Number consenting (inferred from data rather than being an outcome presented by authors)
Notes Overall risk of bias - B: Moderate risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Unclear Participants probably were blind but the investigators were not. Investi-
gators got an independent reviewer to look at a portion of interviews and
he/she thought they were fair. They also used a script so less room for
investigator initiative
Objective outcomes? No Number consenting not presented as an outcome but inferred from data
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Simes 1986
Methods Randomised controlled trial
Data Setting: secondary care, Australia. Patients attending an oncology unit. 57 participants
Comparisons Investigated the effect of different consent methods
Individual approach to consent - patients given information about aims, expected results, potential toxi-
cities of treatment; details of treatment left to discretion of consultant; patients given opportunity to ask
questions, verbal consent obtained. This was compared to total disclosure approach - patients were fully
informed about all trial aspects by consultant: patients given opportunity to ask questions, also given a
consent form outlining the information; this was kept overnight and written consent was obtained the
following day
Outcomes Proportion recruited to trial
Notes Overall risk of bias - A: Low risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Unclear Participants were probably blinded. Clinicians were probably not blinded.
It is not clear if it is the same clinicians provided information in to both
groups
Objective outcomes? Yes Proportion recruited to trial
Treschan 2003
Methods Randomised controlled trial
Data Setting: secondary care, Austria. Participants were patients undergoing minor surgery with general anaes-
thetic, 19 to 80 years old. Exclusion criteria were pain, cancer, unable to give unformed consent, could
not speak German. 150 participants
Comparisons Investigated the effect of mentioning risk or discomfort on recruitment
Intervention A: Said no risk but emphasised the painful nature of tests etc
Intervention B: Said no pain but emphasised risk
Comparator: Said extra oxygen is harmless and the wound evaluations are painless. This study thus poses
essentially no risk and will not produce any significant pain
Outcomes Willingness to participate in a hypothetical trial - patients were not told the trial was hypothetical until
after decision to take part but still not a real decision
Notes Overall risk of bias - B: Moderate risk of bias
Risk of bias
58Strategies to improve recruitment to randomised controlled trials (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Treschan 2003 (Continued)
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Unclear Participantswere blinded (just given general statement that studywas about
pain and risk) but not clear if interviewers were. They were however told
not to give personal comments to influence the decision-making process
Objective outcomes? No Hypothetical trial
Trevena 2006
Methods Randomised controlled trial
Data Setting: primary care, Australia. Patients aged 50 to 74 eligible for a colorectal cancer screening trial. 152
participants
Comparisons Investigated the effect of different trial information methods
Opt-in recruitment; letter from doctor advising that the practice is taking part in screening trial; would
only be contacted if contact details returned. This was compared to opt-out recruitment; letter from
doctor advising that the practice is taking part in screening trial; would be contacted unless the practice
was advised to withhold contact details
The distribution of participants between intervention and comparison groups is uneven: 60 versus 92,
respectively. This was due to a change in legislation in Australia, which meant that the trialists could no
longer continue with the opt-out procedure and had to change to opt-in to keep their ethical approval
Outcomes Proportion recruited to trial
Notes Overall risk of bias - A: Low risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Yes Participants not told about different recruitment methods. Not clear if
clinicians were blinded but they were not involved in recruitment, which
was done by letter and then contact with research team
Objective outcomes? Yes Proportion recruited to trial
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Wadland 1990
Methods Randomised controlled trial
Data Setting: primary care, USA. Participants were smokers, > 18 years old. 104 participants
Comparisons Intervention: Consent form read out by researcher
Comparator: Consent form read by patient
Outcomes Proportion recruited to trial
Notes Only Site 2 in the study ran a randomised evaluation so only its data are included
Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear No details given
Blinding? Unclear Not clear if the participants were told about how consent might be varied
Objective outcomes? Yes Proportion recruited to trial
Weinfurt 2008a
Methods Randomised controlled trial
Data Setting: community, USA. 18 or over and diagnosed with coronary artery disease. 3623 participants
Comparisons Intervention A: Drug company pays investigator running costs plus general statement saying ethics com-
mittee did not think this would affect patient safety
Intervention B: Drug company pays investigator money for things outside the study plus general statement
saying ethics committee did not think this would affect patient safety
Intervention C: Investigator owns part of drug company plus general statement saying ethics committee
did not think this would affect patient safety.
Intervention D: Institution owns part of drug company plus general statement saying ethics committee
did not think this would affect patient safety
Comparator: Generic financial disclosure: general statement about investigator possibly gaining financially
plus general statement saying ethics committee did not think this would affect patient safety
Outcomes Willingness to take part in hypothetical trial
Notes Overall risk of bias - C: High risk of bias
Risk of bias
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Weinfurt 2008a (Continued)
Item Authors’ judgement Description
Allocation concealment? Unclear No details given
Blinding? Unclear Not clear what participants were told about the purpose of the study al-
though there were 5 disclosure statements so everyone got a statement (i.
e. hard to tell which group they were in). Participants completed a ques-
tionnaire (probably) so research team unable to influence
Objective outcomes? No Hypothetical trial
Weinfurt 2008b
Methods Randomised controlled trial
Data Setting: community but recruited through outpatient dept, USA. Participants were 18 or over and diag-
nosed with coronary artery disease. 470 participants
Comparisons Intervention A: Financial disclosure saying that the drug company pays hospital
Intervention B: Financial disclosure saying that the drug company pays the investigator
Comparator: No financial disclosure
Outcomes Willingness to take part in hypothetical trial
Notes Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear No details given
Blinding? Unclear Not clear what participants were told about disclosure study; not clear if
interviewers knew allocation
Objective outcomes? No Hypothetical trial
Welton 1999
Methods Quasi-randomised controlled trial
Data Setting: primary care, UK. Women aged 45 to 64 who had not had a hysterectomy. 436 participants
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Welton 1999 (Continued)
Comparisons Investigated the effect of different trial information methods
Verbal information about a trial of HRT, comparing oestrogen only versus combined oestrogen and
progestogen. This was compared to verbal information about a trial of HRT, comparing oestrogen only,
versus combined oestrogen and progestogen, versus placebo
Outcomes Willingness to take part in hypothetical trial
Notes Overall risk of bias - C: High risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No By week
Blinding? Yes Participants were blinded but the nurses were not
Objective outcomes? No Hypothetical trial
Weston 1997
Methods Randomised controlled trial
Data Setting: secondary care, Canada. Women attending for antenatal visits. 90 participants
Comparisons Investigated the effect of different trial information methods
Written study information followed by viewing of Term Prelabour Rupture of the Membranes (Term
PROM) video. This was compared to written study information only
Outcomes Proportion recruited to hypothetical trial
Notes Overall risk of bias - B: Moderate risk of bias
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Adequate
Blinding? Unclear Depends if the women were told they might watch a video - they probably
were told. Women completed a questionnaire so they were probably not
influenced by the study nurse
Objective outcomes? No Hypothetical trial
HRT: hormone replacement therapy
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NICU: neonatal intensive care unit
RCT: randomised controlled trial
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Aaronson 1996 Not studying a recruitment intervention
Alexander 2008 Not recruiting to a trial
Andrew 1993 Used Zelen design but its use was not part of a randomised evaluation of the design to increase recruitment
Berman 2005 Not randomised
Brealey 2007 Not randomised
Burns 2008 Not studying a recruitment intervention
Caldwell 2002 An earlier version of work later published in a systematic review (Caldwell PHY et al. Strategies for increasing
recruitment to randomised controlled trials: systematic review. PLoS Med 7(11): e1000368), the references
of which were checked for this Cochrane Review
Calimlim 1977 Not studying a recruitment intervention
Celentano 1995 Recruiting to a survey
Chin Feman 2008 Not randomised
Dal-Ré 1991 Not recruiting to a randomised controlled trial (simulated trial was a non-randomised Phase 1 study)
Davis 1998 Not randomised
Donovan 2009 Not randomised
Feman 2008 Not randomised
Gallo 1995 This study presents a subset of the data given in Perrone 1995, which is included in this review
Gillon 2009 Not studying a recruitment intervention
Ginexi 2003 Not randomised
Gitanjali 2003 Allocation not randomised
Gomez 1998 Letter
Halpern 2002 Allocation not randomised
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(Continued)
Jay 2007 Not studying a recruitment intervention
Ji 2008 Allocation not randomised
Junghans 2005 Not recruiting to a trial but to an observational study of patients with angina
Karlawish 2008 Allocation not randomised
Kelechi 2010 Allocation not randomised
Kernan 2009 Hospitals not randomised to intervention
Kiernan 2000 Studying response to an advertisement not actual recruitment
Korde 2009 Allocation not randomised
Kruse 2000 Looking at impact on knowledge, not recruitment
Lancet 2001 Editorial
Lang 1991 Not studying a recruitment intervention
Larkey 2009 Allocation not randomised
Leader 1978 Allocation not randomised
Lichter 1991 Editorial
Lloyd-Williams 2002 Not studying a recruitment intervention
Macias 2005 Not studying a recruitment intervention
Marco 2008 Not recruiting to a trial
Masood 2006 Not recruiting to a trial
May 2007 Not studying a recruitment intervention
Menoyo 2006 Not studying a recruitment intervention
Monane 1991 Not studying a recruitment intervention
Olver 2009 Not recruiting to a trial
Paskett 2002 Allocation not randomised
Perri 2006 Allocation not randomised
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(Continued)
Quinaux 2003 An earlier version of Liénard 2006, which is included in this review
Rogers 1998 Studying recall, understanding and satisfaction rather than effect on recruitment
Saul 2002 News item
Scholes 2007 Not recruiting to a trial
Schrott 1982 Not studying a recruitment intervention
Ubel 1997 Allocation not randomised
Unger 2006 Not studying a recruitment intervention
Wragg 2000 Allocation not randomised
Yates 2009 Not randomised
The majority of the studies that we considered in detail but excluded arose from articles that we ordered because the database reference
gave no abstract and it was not possible to exclude on the basis of the title. The majority of articles falling into this category were
excluded as soon as the full text was checked, with the most common reason being that the study did not evaluate a recruitment
intervention.
The two exceptions are Aaronson 1996 and Kiernan 2000, which we excluded at the data extraction stage for the reasons given in the
table.
Characteristics of studies awaiting assessment [ordered by study ID]
Brocklehurst 2007
Methods
Data
Comparisons
Outcomes
Notes Full text to be obtained
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Cramer 1993
Methods
Data
Comparisons
Outcomes
Notes Full text to be obtained
Free 2011
Methods Recruitment method evaluation embedded in Txt2Stop trial
Data
Comparisons Text message reminder suggesting places on trial were scarce versus just text message reminder
Outcomes Number recruited
Notes Published after search was run but looks like it will be included in next update
Glen 1980
Methods
Data
Comparisons
Outcomes
Notes Full text to be obtained
Greenlee 2003
Methods
Data
Comparisons
Outcomes
Notes Full text to be obtained
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D A T A A N D A N A L Y S E S
Comparison 1. Open RCT vs Blinded RCT
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 2 4833 Risk Ratio (M-H, Random, 95% CI) 1.22 [1.09, 1.36]
Comparison 2. Placebo vs other comparator
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 436 Risk Ratio (M-H, Fixed, 95% CI) 0.76 [0.59, 0.99]
Comparison 3. Patient preference design vs conventional RCT
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 273 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.81, 1.11]
Comparison 4. Opt-out consent vs opt-in consent
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 152 Risk Ratio (M-H, Fixed, 95% CI) 1.39 [1.06, 1.84]
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Comparison 5. Consent to experimental care vs usual consent
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 2 2456 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.98, 1.05]
Comparison 6. Consent to standard care vs usual consent
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 2 1759 Risk Ratio (M-H, Random, 95% CI) 0.76 [0.49, 1.17]
Comparison 7. Refusers choose treatment vs usual consent
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 1592 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.89, 0.98]
Comparison 8. Physician-modified consent vs usual consent
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 301 Risk Ratio (M-H, Fixed, 95% CI) 1.09 [0.90, 1.32]
Comparison 9. Participant-modified consent vs usual consent
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 301 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.83, 1.24]
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Comparison 10. Researcher reading out consent vs participant reading consent
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 104 Risk Ratio (M-H, Fixed, 95% CI) 1.12 [0.76, 1.65]
Comparison 11. Educational audiovisual information vs standard information
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 3 495 Risk Ratio (M-H, Random, 95% CI) 1.20 [0.75, 1.91]
Comparison 12. Educational audiovisual information + written information vs written information
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 90 Risk Ratio (M-H, Fixed, 95% CI) 1.75 [1.11, 2.74]
Comparison 13. Educational audiovisual information + help vs standard information + general audiovisual
information + help
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 128 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.78, 1.27]
Comparison 14. Telephone reminder vs no telephone reminder
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 2 Odds Ratio (Random, 95% CI) 1.95 [1.04, 3.66]
69Strategies to improve recruitment to randomised controlled trials (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Comparison 15. Telephone reminder + questionnaire vs no reminder or questionnaire
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 280 Risk Ratio (M-H, Fixed, 95% CI) 1.17 [0.90, 1.51]
Comparison 16. Telephone screening vs face-to-face screening
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 469 Risk Ratio (M-H, Fixed, 95% CI) 1.26 [1.06, 1.50]
Comparison 17. SMS messages containing quotes from existing participants vs no messages
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 811 Risk Ratio (M-H, Fixed, 95% CI) 35.09 [2.12, 581.48]
Comparison 18. Enhanced recruitment package + recruitment at churches vs standard recruitment package
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 6246 Risk Ratio (M-H, Fixed, 95% CI) 1.37 [1.05, 1.78]
Comparison 19. Enhanced recruitment package vs standard recruitment package
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 6376 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.65, 1.18]
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Comparison 20. Enhanced recruitment package + baseline data over telephone vs standard recruitment package
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 6372 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.74, 1.31]
Comparison 21. Electronic completion of screening questionnaire vs standard paper completion
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 292 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.67, 1.07]
Comparison 22. Oral completion of screening questionnaire vs standard paper completion
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 219 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.77, 1.29]
Comparison 23. Study-related questionnaire + trial invitation vs trial invitation
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 2 Odds Ratio (Random, 95% CI) 1.17 [0.74, 1.87]
Comparison 24. Clinical trial booklet + standard information vs standard information
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 2 91 Risk Ratio (M-H, Random, 95% CI) 1.11 [0.71, 1.72]
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Comparison 25. Negative framing of side effects vs neutral framing
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 60 Risk Ratio (M-H, Fixed, 95% CI) 0.87 [0.63, 1.20]
Comparison 26. Positive framing of side effects vs neutral framing
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 60 Risk Ratio (M-H, Fixed, 95% CI) 0.78 [0.55, 1.11]
Comparison 27. Less detailed presentation of risk and other information vs more detailed presentation
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 19 Risk Ratio (M-H, Fixed, 95% CI) 1.2 [0.36, 3.97]
Comparison 28. Information leaflet with explanation vs information leaflet without explanation
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 37 Risk Ratio (M-H, Fixed, 95% CI) 1.51 [0.73, 3.10]
Comparison 29. Brief counselling + print materials vs print alone
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 450 Risk Ratio (M-H, Fixed, 95% CI) 1.14 [1.01, 1.28]
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Comparison 30. Emphasising pain in information vs standard information
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 98 Risk Ratio (M-H, Fixed, 95% CI) 0.55 [0.36, 0.85]
Comparison 31. Emphasising risk in information vs standard information
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 97 Risk Ratio (M-H, Fixed, 95% CI) 0.41 [0.24, 0.68]
Comparison 32. Newspaper article + study information vs study information only
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 4488 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.75, 1.42]
Comparison 33. More favourable newspaper article + study information vs Less favourable newspaper article +
study information
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 2745 Risk Ratio (M-H, Fixed, 95% CI) 1.05 [0.73, 1.52]
Comparison 34. Interactive computer presentation of trial information vs standard paper presentations
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 60 Risk Ratio (M-H, Fixed, 95% CI) 1.35 [0.93, 1.96]
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Comparison 35. Interactive computer presentation of trial information vs audio-taped presentation
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 100 Risk Ratio (M-H, Fixed, 95% CI) 1.48 [1.00, 2.18]
Comparison 36. Writing treatment effect is ’twice as fast’ in trial information vs writing ’half as fast’
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 100 Risk Ratio (M-H, Fixed, 95% CI) 1.62 [1.10, 2.37]
Comparison 37. Total information disclosure vs standard disclosure
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 57 Risk Ratio (M-H, Fixed, 95% CI) 1.13 [0.93, 1.38]
Comparison 38. One new vs both standard (intervention description)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 124 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.66, 0.99]
Comparison 39. Screening by senior investigator vs screening by research assistant
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 347 Risk Ratio (M-H, Fixed, 95% CI) 1.45 [0.87, 2.44]
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Comparison 40. Financial incentive vs no incentive
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Participant recruited 1 491 Risk Ratio (M-H, Fixed, 95% CI) 12.95 [1.71, 98.21]
Analysis 1.1. Comparison 1 Open RCT vs Blinded RCT, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 1 Open RCT vs Blinded RCT
Outcome: 1 Participant recruited
Study or subgroup Open Blinded Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Hemminki 2004 134/180 233/358 41.8 % 1.14 [ 1.02, 1.28 ]
Avenell 2004 1027/2159 796/2136 58.2 % 1.28 [ 1.19, 1.37 ]
Total (95% CI) 2339 2494 100.0 % 1.22 [ 1.09, 1.36 ]
Total events: 1161 (Open), 1029 (Blinded)
Heterogeneity: Tau2 = 0.00; Chi2 = 2.74, df = 1 (P = 0.10); I2 =64%
Test for overall effect: Z = 3.54 (P = 0.00041)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours blinded Favours open
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Analysis 2.1. Comparison 2 Placebo vs other comparator, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 2 Placebo vs other comparator
Outcome: 1 Participant recruited
Study or subgroup Placebo Other comparator Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Welton 1999 65/218 85/218 100.0 % 0.76 [ 0.59, 0.99 ]
Total (95% CI) 218 218 100.0 % 0.76 [ 0.59, 0.99 ]
Total events: 65 (Placebo), 85 (Other comparator)
Heterogeneity: not applicable
Test for overall effect: Z = 2.00 (P = 0.045)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours other comparator Favours placebo
Analysis 3.1. Comparison 3 Patient preference design vs conventional RCT, Outcome 1 Participant
recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 3 Patient preference design vs conventional RCT
Outcome: 1 Participant recruited
Study or subgroup
Patient
preference
design Conventional design Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cooper 1997 90/135 97/138 100.0 % 0.95 [ 0.81, 1.11 ]
Total (95% CI) 135 138 100.0 % 0.95 [ 0.81, 1.11 ]
Total events: 90 (Patient preference design), 97 (Conventional design)
Heterogeneity: not applicable
Test for overall effect: Z = 0.64 (P = 0.52)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours conventional Favours preference
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Analysis 4.1. Comparison 4 Opt-out consent vs opt-in consent, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 4 Opt-out consent vs opt-in consent
Outcome: 1 Participant recruited
Study or subgroup Opt-out Opt-in Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Trevena 2006 40/60 44/92 100.0 % 1.39 [ 1.06, 1.84 ]
Total (95% CI) 60 92 100.0 % 1.39 [ 1.06, 1.84 ]
Total events: 40 (Opt-out), 44 (Opt-in)
Heterogeneity: not applicable
Test for overall effect: Z = 2.34 (P = 0.019)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours opt-in Favours opt-out
Analysis 5.1. Comparison 5 Consent to experimental care vs usual consent, Outcome 1 Participant
recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 5 Consent to experimental care vs usual consent
Outcome: 1 Participant recruited
Study or subgroup
Consent to
experimen-
tal Usual consent Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Myles 1999 90/169 84/151 9.0 % 0.96 [ 0.78, 1.17 ]
Perrone 1995 997/1151 836/985 91.0 % 1.02 [ 0.99, 1.06 ]
Total (95% CI) 1320 1136 100.0 % 1.01 [ 0.98, 1.05 ]
Total events: 1087 (Consent to experimental), 920 (Usual consent)
Heterogeneity: Chi2 = 0.42, df = 1 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 0.80 (P = 0.42)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours usual consent Favours experimental only
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Analysis 6.1. Comparison 6 Consent to standard care vs usual consent, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 6 Consent to standard care vs usual consent
Outcome: 1 Participant recruited
Study or subgroup Consent to standard Usual consent Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Myles 1999 79/149 84/151 47.7 % 0.95 [ 0.77, 1.17 ]
Perrone 1995 246/474 836/985 52.3 % 0.61 [ 0.56, 0.67 ]
Total (95% CI) 623 1136 100.0 % 0.76 [ 0.49, 1.17 ]
Total events: 325 (Consent to standard), 920 (Usual consent)
Heterogeneity: Tau2 = 0.09; Chi2 = 14.74, df = 1 (P = 0.00012); I2 =93%
Test for overall effect: Z = 1.26 (P = 0.21)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours usual consent Favours standard only
Analysis 7.1. Comparison 7 Refusers choose treatment vs usual consent, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 7 Refusers choose treatment vs usual consent
Outcome: 1 Participant recruited
Study or subgroup Refusers choose Usual consent Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Perrone 1995 482/607 836/985 100.0 % 0.94 [ 0.89, 0.98 ]
Total (95% CI) 607 985 100.0 % 0.94 [ 0.89, 0.98 ]
Total events: 482 (Refusers choose), 836 (Usual consent)
Heterogeneity: not applicable
Test for overall effect: Z = 2.70 (P = 0.0069)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours usual consent Favours refusers choose
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Analysis 8.1. Comparison 8 Physician-modified consent vs usual consent, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 8 Physician-modified consent vs usual consent
Outcome: 1 Participant recruited
Study or subgroup Physician modified Usual consent Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Myles 1999 91/150 84/151 100.0 % 1.09 [ 0.90, 1.32 ]
Total (95% CI) 150 151 100.0 % 1.09 [ 0.90, 1.32 ]
Total events: 91 (Physician modified), 84 (Usual consent)
Heterogeneity: not applicable
Test for overall effect: Z = 0.88 (P = 0.38)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours usual consent Favours physician mod
Analysis 9.1. Comparison 9 Participant-modified consent vs usual consent, Outcome 1 Participant
recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 9 Participant-modified consent vs usual consent
Outcome: 1 Participant recruited
Study or subgroup Participant modified Usual consent Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Myles 1999 85/150 84/151 100.0 % 1.02 [ 0.83, 1.24 ]
Total (95% CI) 150 151 100.0 % 1.02 [ 0.83, 1.24 ]
Total events: 85 (Participant modified), 84 (Usual consent)
Heterogeneity: not applicable
Test for overall effect: Z = 0.18 (P = 0.86)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours usual consent Favours participant mod
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Analysis 10.1. Comparison 10 Researcher reading out consent vs participant reading consent, Outcome 1
Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 10 Researcher reading out consent vs participant reading consent
Outcome: 1 Participant recruited
Study or subgroup Researcher reads Participant reads Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wadland 1990 27/51 25/53 100.0 % 1.12 [ 0.76, 1.65 ]
Total (95% CI) 51 53 100.0 % 1.12 [ 0.76, 1.65 ]
Total events: 27 (Researcher reads), 25 (Participant reads)
Heterogeneity: not applicable
Test for overall effect: Z = 0.59 (P = 0.56)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours participant Favours researcher
Analysis 11.1. Comparison 11 Educational audiovisual information vs standard information, Outcome 1
Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 11 Educational audiovisual information vs standard information
Outcome: 1 Participant recruited
Study or subgroup AV information Usual information Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Du 2008 16/63 10/63 25.7 % 1.60 [ 0.79, 3.25 ]
Du 2009 10/98 6/98 16.9 % 1.67 [ 0.63, 4.41 ]
Hutchison 2007 62/86 66/87 57.3 % 0.95 [ 0.80, 1.13 ]
Total (95% CI) 247 248 100.0 % 1.20 [ 0.75, 1.91 ]
Total events: 88 (AV information), 82 (Usual information)
Heterogeneity: Tau2 = 0.09; Chi2 = 4.00, df = 2 (P = 0.14); I2 =50%
Test for overall effect: Z = 0.75 (P = 0.46)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
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Analysis 12.1. Comparison 12 Educational audiovisual information + written information vs written
information, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 12 Educational audiovisual information + written information vs written information
Outcome: 1 Participant recruited
Study or subgroup AV+written Written Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Weston 1997 26/42 17/48 100.0 % 1.75 [ 1.11, 2.74 ]
Total (95% CI) 42 48 100.0 % 1.75 [ 1.11, 2.74 ]
Total events: 26 (AV+written), 17 (Written)
Heterogeneity: not applicable
Test for overall effect: Z = 2.43 (P = 0.015)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours written Favours AV+written
Analysis 13.1. Comparison 13 Educational audiovisual information + help vs standard information + general
audiovisual information + help, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 13 Educational audiovisual information + help vs standard information + general audiovisual information + help
Outcome: 1 Participant recruited
Study or subgroup AV+help Usual+general AV Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Jeste 2009 41/62 44/66 100.0 % 0.99 [ 0.78, 1.27 ]
Total (95% CI) 62 66 100.0 % 0.99 [ 0.78, 1.27 ]
Total events: 41 (AV+help), 44 (Usual+general AV)
Heterogeneity: not applicable
Test for overall effect: Z = 0.06 (P = 0.95)
Test for subgroup differences: Not applicable
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81Strategies to improve recruitment to randomised controlled trials (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 14.1. Comparison 14 Telephone reminder vs no telephone reminder, Outcome 1 Participant
recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 14 Telephone reminder vs no telephone reminder
Outcome: 1 Participant recruited
Study or subgroup log [Odds Ratio] Odds Ratio Weight Odds Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Harris 2008 0.405 (0.212) 60.1 % 1.50 [ 0.99, 2.27 ]
Nystuen 2004 1.061 (0.363) 39.9 % 2.89 [ 1.42, 5.89 ]
Total (95% CI) 100.0 % 1.95 [ 1.04, 3.66 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 2.44, df = 1 (P = 0.12); I2 =59%
Test for overall effect: Z = 2.08 (P = 0.038)
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
Favours no reminder Favours reminder
Analysis 15.1. Comparison 15 Telephone reminder + questionnaire vs no reminder or questionnaire,
Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 15 Telephone reminder + questionnaire vs no reminder or questionnaire
Outcome: 1 Participant recruited
Study or subgroup Reminder+questionnaireNo reminder or Q Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Harris 2008 69/140 59/140 100.0 % 1.17 [ 0.90, 1.51 ]
Total (95% CI) 140 140 100.0 % 1.17 [ 0.90, 1.51 ]
Total events: 69 (Reminder+questionnaire), 59 (No reminder or Q)
Heterogeneity: not applicable
Test for overall effect: Z = 1.20 (P = 0.23)
Test for subgroup differences: Not applicable
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Favours no reminder or Q Favours reminder+Q
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Analysis 16.1. Comparison 16 Telephone screening vs face-to-face screening, Outcome 1 Participant
recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 16 Telephone screening vs face-to-face screening
Outcome: 1 Participant recruited
Study or subgroup Telephone screening
Face-to-
face
screening Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Diguiseppi 2006 64/99 190/370 100.0 % 1.26 [ 1.06, 1.50 ]
Total (95% CI) 99 370 100.0 % 1.26 [ 1.06, 1.50 ]
Total events: 64 (Telephone screening), 190 (Face-to-face screening)
Heterogeneity: not applicable
Test for overall effect: Z = 2.56 (P = 0.010)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours face-to-face Favours telephone
Analysis 17.1. Comparison 17 SMS messages containing quotes from existing participants vs no messages,
Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 17 SMS messages containing quotes from existing participants vs no messages
Outcome: 1 Participant recruited
Study or subgroup SMS No SMS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Free 2010 17/405 0/406 100.0 % 35.09 [ 2.12, 581.48 ]
Total (95% CI) 405 406 100.0 % 35.09 [ 2.12, 581.48 ]
Total events: 17 (SMS), 0 (No SMS)
Heterogeneity: not applicable
Test for overall effect: Z = 2.48 (P = 0.013)
Test for subgroup differences: Not applicable
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Analysis 18.1. Comparison 18 Enhanced recruitment package + recruitment at churches vs standard
recruitment package, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 18 Enhanced recruitment package + recruitment at churches vs standard recruitment package
Outcome: 1 Participant recruited
Study or subgroup Enhanced+churches Standard Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ford 2004 116/2949 95/3297 100.0 % 1.37 [ 1.05, 1.78 ]
Total (95% CI) 2949 3297 100.0 % 1.37 [ 1.05, 1.78 ]
Total events: 116 (Enhanced+churches), 95 (Standard)
Heterogeneity: not applicable
Test for overall effect: Z = 2.29 (P = 0.022)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours standard Favours enhanced+churches
Analysis 19.1. Comparison 19 Enhanced recruitment package vs standard recruitment package, Outcome 1
Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 19 Enhanced recruitment package vs standard recruitment package
Outcome: 1 Participant recruited
Study or subgroup Enhanced Standard Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ford 2004 78/3079 95/3297 100.0 % 0.88 [ 0.65, 1.18 ]
Total (95% CI) 3079 3297 100.0 % 0.88 [ 0.65, 1.18 ]
Total events: 78 (Enhanced), 95 (Standard)
Heterogeneity: not applicable
Test for overall effect: Z = 0.85 (P = 0.39)
Test for subgroup differences: Not applicable
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Favours standard Favours enhanced
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Analysis 20.1. Comparison 20 Enhanced recruitment package + baseline data over telephone vs standard
recruitment package, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 20 Enhanced recruitment package + baseline data over telephone vs standard recruitment package
Outcome: 1 Participant recruited
Study or subgroup Enhanced+phone Standard Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ford 2004 87/3075 95/3297 100.0 % 0.98 [ 0.74, 1.31 ]
Total (95% CI) 3075 3297 100.0 % 0.98 [ 0.74, 1.31 ]
Total events: 87 (Enhanced+phone), 95 (Standard)
Heterogeneity: not applicable
Test for overall effect: Z = 0.12 (P = 0.90)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours standard Favours enhanced+phone
Analysis 21.1. Comparison 21 Electronic completion of screening questionnaire vs standard paper
completion, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 21 Electronic completion of screening questionnaire vs standard paper completion
Outcome: 1 Participant recruited
Study or subgroup Electronic completion Paper Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Graham 2007 69/151 76/141 100.0 % 0.85 [ 0.67, 1.07 ]
Total (95% CI) 151 141 100.0 % 0.85 [ 0.67, 1.07 ]
Total events: 69 (Electronic completion), 76 (Paper)
Heterogeneity: not applicable
Test for overall effect: Z = 1.40 (P = 0.16)
Test for subgroup differences: Not applicable
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Analysis 22.1. Comparison 22 Oral completion of screening questionnaire vs standard paper completion,
Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 22 Oral completion of screening questionnaire vs standard paper completion
Outcome: 1 Participant recruited
Study or subgroup Oral completion Paper Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Graham 2007 42/78 76/141 100.0 % 1.00 [ 0.77, 1.29 ]
Total (95% CI) 78 141 100.0 % 1.00 [ 0.77, 1.29 ]
Total events: 42 (Oral completion), 76 (Paper)
Heterogeneity: not applicable
Test for overall effect: Z = 0.01 (P = 0.99)
Test for subgroup differences: Not applicable
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Favours paper Favours oral
Analysis 23.1. Comparison 23 Study-related questionnaire + trial invitation vs trial invitation, Outcome 1
Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 23 Study-related questionnaire + trial invitation vs trial invitation
Outcome: 1 Participant recruited
Study or subgroup log [Odds Ratio] Odds Ratio Weight Odds Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Harris 2008 -0.105 (0.197) 44.3 % 0.90 [ 0.61, 1.32 ]
Kendrick 2001 0.372 (0.113) 55.7 % 1.45 [ 1.16, 1.81 ]
Total (95% CI) 100.0 % 1.17 [ 0.74, 1.87 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 4.41, df = 1 (P = 0.04); I2 =77%
Test for overall effect: Z = 0.68 (P = 0.50)
Test for subgroup differences: Not applicable
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Analysis 24.1. Comparison 24 Clinical trial booklet + standard information vs standard information,
Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 24 Clinical trial booklet + standard information vs standard information
Outcome: 1 Participant recruited
Study or subgroup Booklet Standard Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Ellis 2002 12/30 14/30 36.3 % 0.86 [ 0.48, 1.53 ]
Ives 2001 15/16 11/15 63.7 % 1.28 [ 0.92, 1.78 ]
Total (95% CI) 46 45 100.0 % 1.11 [ 0.71, 1.72 ]
Total events: 27 (Booklet), 25 (Standard)
Heterogeneity: Tau2 = 0.05; Chi2 = 1.87, df = 1 (P = 0.17); I2 =46%
Test for overall effect: Z = 0.45 (P = 0.65)
Test for subgroup differences: Not applicable
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Favours standard Favours booklet
Analysis 25.1. Comparison 25 Negative framing of side effects vs neutral framing, Outcome 1 Participant
recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 25 Negative framing of side effects vs neutral framing
Outcome: 1 Participant recruited
Study or subgroup Negative framing Neutral framing Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Llewellyn-Thomas 1995a 20/30 23/30 100.0 % 0.87 [ 0.63, 1.20 ]
Total (95% CI) 30 30 100.0 % 0.87 [ 0.63, 1.20 ]
Total events: 20 (Negative framing), 23 (Neutral framing)
Heterogeneity: not applicable
Test for overall effect: Z = 0.85 (P = 0.39)
Test for subgroup differences: Not applicable
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Analysis 26.1. Comparison 26 Positive framing of side effects vs neutral framing, Outcome 1 Participant
recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 26 Positive framing of side effects vs neutral framing
Outcome: 1 Participant recruited
Study or subgroup Positive framing Neutral framing Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Llewellyn-Thomas 1995a 18/30 23/30 100.0 % 0.78 [ 0.55, 1.11 ]
Total (95% CI) 30 30 100.0 % 0.78 [ 0.55, 1.11 ]
Total events: 18 (Positive framing), 23 (Neutral framing)
Heterogeneity: not applicable
Test for overall effect: Z = 1.36 (P = 0.17)
Test for subgroup differences: Not applicable
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Analysis 27.1. Comparison 27 Less detailed presentation of risk and other information vs more detailed
presentation, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 27 Less detailed presentation of risk and other information vs more detailed presentation
Outcome: 1 Participant recruited
Study or subgroup Less detailed More detailed Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Freer 2009 4/10 3/9 100.0 % 1.20 [ 0.36, 3.97 ]
Total (95% CI) 10 9 100.0 % 1.20 [ 0.36, 3.97 ]
Total events: 4 (Less detailed), 3 (More detailed)
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.77)
Test for subgroup differences: Not applicable
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Analysis 28.1. Comparison 28 Information leaflet with explanation vs information leaflet without
explanation, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 28 Information leaflet with explanation vs information leaflet without explanation
Outcome: 1 Participant recruited
Study or subgroup Leaflet+explanation Leaflet Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Freer 2009 10/18 7/19 100.0 % 1.51 [ 0.73, 3.10 ]
Total (95% CI) 18 19 100.0 % 1.51 [ 0.73, 3.10 ]
Total events: 10 (Leaflet+explanation), 7 (Leaflet)
Heterogeneity: not applicable
Test for overall effect: Z = 1.12 (P = 0.26)
Test for subgroup differences: Not applicable
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Favours leaflet Favours leaflet+exp
Analysis 29.1. Comparison 29 Brief counselling + print materials vs print alone, Outcome 1 Participant
recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 29 Brief counselling + print materials vs print alone
Outcome: 1 Participant recruited
Study or subgroup Councelling+print Print Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Mandelblatt 2005 178/232 147/218 100.0 % 1.14 [ 1.01, 1.28 ]
Total (95% CI) 232 218 100.0 % 1.14 [ 1.01, 1.28 ]
Total events: 178 (Councelling+print), 147 (Print)
Heterogeneity: not applicable
Test for overall effect: Z = 2.18 (P = 0.030)
Test for subgroup differences: Not applicable
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Favours print Favours counselling+print
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Analysis 30.1. Comparison 30 Emphasising pain in information vs standard information, Outcome 1
Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 30 Emphasising pain in information vs standard information
Outcome: 1 Participant recruited
Study or subgroup Emphasise pain Standard Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Treschan 2003 18/51 30/47 100.0 % 0.55 [ 0.36, 0.85 ]
Total (95% CI) 51 47 100.0 % 0.55 [ 0.36, 0.85 ]
Total events: 18 (Emphasise pain), 30 (Standard)
Heterogeneity: not applicable
Test for overall effect: Z = 2.70 (P = 0.0068)
Test for subgroup differences: Not applicable
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Favours standard Favours pain
Analysis 31.1. Comparison 31 Emphasising risk in information vs standard information, Outcome 1
Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 31 Emphasising risk in information vs standard information
Outcome: 1 Participant recruited
Study or subgroup Emphasise risk Standard Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Treschan 2003 13/50 30/47 100.0 % 0.41 [ 0.24, 0.68 ]
Total (95% CI) 50 47 100.0 % 0.41 [ 0.24, 0.68 ]
Total events: 13 (Emphasise risk), 30 (Standard)
Heterogeneity: not applicable
Test for overall effect: Z = 3.42 (P = 0.00063)
Test for subgroup differences: Not applicable
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Analysis 32.1. Comparison 32 Newspaper article + study information vs study information only, Outcome 1
Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 32 Newspaper article + study information vs study information only
Outcome: 1 Participant recruited
Study or subgroup Newspaper+informationStudy information Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Pighills 2009 73/2243 71/2245 100.0 % 1.03 [ 0.75, 1.42 ]
Total (95% CI) 2243 2245 100.0 % 1.03 [ 0.75, 1.42 ]
Total events: 73 (Newspaper+information), 71 (Study information)
Heterogeneity: not applicable
Test for overall effect: Z = 0.17 (P = 0.86)
Test for subgroup differences: Not applicable
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Analysis 33.1. Comparison 33 More favourable newspaper article + study information vs Less favourable
newspaper article + study information, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 33 More favourable newspaper article + study information vs Less favourable newspaper article + study information
Outcome: 1 Participant recruited
Study or subgroup
Favourable
newspaper Less favourable Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Pighills 2009 57/1374 54/1371 100.0 % 1.05 [ 0.73, 1.52 ]
Total (95% CI) 1374 1371 100.0 % 1.05 [ 0.73, 1.52 ]
Total events: 57 (Favourable newspaper), 54 (Less favourable)
Heterogeneity: not applicable
Test for overall effect: Z = 0.28 (P = 0.78)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours less favourable Favours more favourable
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Analysis 34.1. Comparison 34 Interactive computer presentation of trial information vs standard paper
presentations, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 34 Interactive computer presentation of trial information vs standard paper presentations
Outcome: 1 Participant recruited
Study or subgroup
Computer
presenta-
tion Paper Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Karunaratne 2010 23/30 17/30 100.0 % 1.35 [ 0.93, 1.96 ]
Total (95% CI) 30 30 100.0 % 1.35 [ 0.93, 1.96 ]
Total events: 23 (Computer presentation), 17 (Paper)
Heterogeneity: not applicable
Test for overall effect: Z = 1.60 (P = 0.11)
Test for subgroup differences: Not applicable
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Analysis 35.1. Comparison 35 Interactive computer presentation of trial information vs audio-taped
presentation, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 35 Interactive computer presentation of trial information vs audio-taped presentation
Outcome: 1 Participant recruited
Study or subgroup
Computer
presenta-
tion Audio presentation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Llewellyn-Thomas 1995b 31/50 21/50 100.0 % 1.48 [ 1.00, 2.18 ]
Total (95% CI) 50 50 100.0 % 1.48 [ 1.00, 2.18 ]
Total events: 31 (Computer presentation), 21 (Audio presentation)
Heterogeneity: not applicable
Test for overall effect: Z = 1.95 (P = 0.051)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours audio Favours computer
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Analysis 36.1. Comparison 36 Writing treatment effect is ’twice as fast’ in trial information vs writing ’half
as fast’, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 36 Writing treatment effect is ’twice as fast’ in trial information vs writing ’half as fast’
Outcome: 1 Participant recruited
Study or subgroup Twice as fast Half as fast Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Simel 1991 35/52 20/48 100.0 % 1.62 [ 1.10, 2.37 ]
Total (95% CI) 52 48 100.0 % 1.62 [ 1.10, 2.37 ]
Total events: 35 (Twice as fast), 20 (Half as fast)
Heterogeneity: not applicable
Test for overall effect: Z = 2.44 (P = 0.015)
Test for subgroup differences: Not applicable
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Analysis 37.1. Comparison 37 Total information disclosure vs standard disclosure, Outcome 1 Participant
recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 37 Total information disclosure vs standard disclosure
Outcome: 1 Participant recruited
Study or subgroup Total disclosure Standard Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Simes 1986 27/29 23/28 100.0 % 1.13 [ 0.93, 1.38 ]
Total (95% CI) 29 28 100.0 % 1.13 [ 0.93, 1.38 ]
Total events: 27 (Total disclosure), 23 (Standard)
Heterogeneity: not applicable
Test for overall effect: Z = 1.23 (P = 0.22)
Test for subgroup differences: Not applicable
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Analysis 38.1. Comparison 38 One new vs both standard (intervention description), Outcome 1 Participant
recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 38 One new vs both standard (intervention description)
Outcome: 1 Participant recruited
Study or subgroup
Intervention
new therapy
Intervention
standard Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Kerr 2004 43/64 50/60 100.0 % 0.81 [ 0.66, 0.99 ]
Total (95% CI) 64 60 100.0 % 0.81 [ 0.66, 0.99 ]
Total events: 43 (Intervention new therapy), 50 (Intervention standard)
Heterogeneity: not applicable
Test for overall effect: Z = 2.06 (P = 0.040)
Test for subgroup differences: Not applicable
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Analysis 39.1. Comparison 39 Screening by senior investigator vs screening by research assistant, Outcome
1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 39 Screening by senior investigator vs screening by research assistant
Outcome: 1 Participant recruited
Study or subgroup Senior investigator Research assistant Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Miller 1999 28/162 22/185 100.0 % 1.45 [ 0.87, 2.44 ]
Total (95% CI) 162 185 100.0 % 1.45 [ 0.87, 2.44 ]
Total events: 28 (Senior investigator), 22 (Research assistant)
Heterogeneity: not applicable
Test for overall effect: Z = 1.42 (P = 0.16)
Test for subgroup differences: Not applicable
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Analysis 40.1. Comparison 40 Financial incentive vs no incentive, Outcome 1 Participant recruited.
Review: Strategies to improve recruitment to randomised controlled trials
Comparison: 40 Financial incentive vs no incentive
Outcome: 1 Participant recruited
Study or subgroup Financial incentive No incentive Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Free 2010 13/246 1/245 100.0 % 12.95 [ 1.71, 98.21 ]
Total (95% CI) 246 245 100.0 % 12.95 [ 1.71, 98.21 ]
Total events: 13 (Financial incentive), 1 (No incentive)
Heterogeneity: not applicable
Test for overall effect: Z = 2.48 (P = 0.013)
Test for subgroup differences: Not applicable
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Favours no incentive Favours incentive
A D D I T I O N A L T A B L E S
Table 1. Intervention categories
Intervention category Studies
Design (e.g. use of an active comparator instead of placebo, or
electronic data collection rather than paper)
Avenell 2004, Cooper 1997, Fowell 2006, Hemminki 2004,
Litchfield 2005, Welton 1999*
Modification to the consent form or process (e.g. consenting to be
randomised to the experimental treatment versus standard con-
sent)
Coyne 2003, Myles 1999*, Perrone 1995*, Trevena 2006,
Wadland 1990
Modification to the approach made to potential participants (e.g.
different patient information leaflets, or video information versus
written information)
Diguiseppi 2006*, Du 2008, Du 2009, Ellis 2002*, Ford 2004,
Free 2010†, Freer 2009*, Fureman 1997*, Graham 2007*, Harris
2008, Hutchison 2007, Ives 2001, Jeste 2009*, Karunaratne
2010*, Kendrick 2001, Kerr 2004*, Kimmick 2005, Llewellyn-
Thomas 1995a*, Llewellyn-Thomas 1995b*, Mandelblatt 2005,
Miller 1999, Nystuen 2004, Pighills 2009, Simel 1991*, Simes
1986, Treschan 2003*, Weinfurt 2008a*, Weinfurt 2008b*,
Weston 1997
Financial incentives for participants Bentley 2004*, Free 2010†, Halpern 2004*
Modification to the training given to recruiters (e.g. extra educa-
tional sessions)
Larkey 2002
Greater contact between trial co-ordinator and trial sites Liénard 2006, Monaghan 2007
Studies marked with * were recruiting to hypothetical trials. †Free 2010 evaluated interventions in two categories.
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A P P E N D I C E S
Appendix 1. Search strategies
CMR The Cochrane Library Online
#1 “accrual and sample size”:kw or “attitudes to trials”:kw or Òinformed consentÓ:kw
#2 (participat* or recruit* or enrol* or select*) near/8 (trial* or research or study):ti or (participat* or recruit* or enrol* or select*) near/
8 (trial* or research or study):ab
#3 (#1 OR #2)
MEDLINE Ovid
1. Patient Selection/
2. ((participat$ or recruit$ or enrol$) adj4 trial?).tw.
3. 1 or 2
4. Informed Consent/
5. informed consent.tw.
6. 4 or 5
7. exp Clinical Trial as Topic/
8. Research Subjects/
9. (trial? or study or studies or research).tw.
10. 7 or 8 or 9
11. 3 or (6 and 10)
12. Research Support, NIH, Extramural.pt.
13. Research Support, NIH, Intramural.pt.
14. Research Support, Non US Gov’t.pt.
15. Research Support, US Gov’t, Non PHS.pt.
16. Research Support, US Gov’t, PHS.pt.
17. recruitment.ab. /freq=2
18. participation.ab. /freq=2
19. research.tw.
20. or/12-19
21. randomized controlled trial.pt.
22. controlled clinical trial.pt.
23. random$.ab.
24. 21 or 22 or 23
25. humans.sh.
26. 24 and 25
27. comment.pt.
28. editorial.pt.
29. 26 not (27 or 28)
30. 11 and 20 and 29
31. 2001$.ed.
32. 2002$.ed.
33. 2003$.ed.
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34. 2004$.ed.
35. 2005$.ed.
36. 2006$.ed.
37. 2007$.ed.
38. 2008$.ed,ep,yr.
39. 2009$.ed,ep,yr.
40. 2010$.ed,ep,yr.
41. or/31-40
42. 30 and 41
EMBASE Ovid
1. ((participat$ or recruit$ or enrol$ or enter$ or entry) and (trial? or study)).ti.
2. (select$ adj3 (participants or patients or controls)).tw.
3. recruit$.ab. /freq=2
4. participat$.ab. /freq=2
5. research.tw.
6. 2 and (3 or 4 or 5)
7. (informed consent or consent process$ or consent procedure?).tw.
8. exp Clinical Trial/
9. (trial? or study or studies or research).tw.
10. 7 and (8 or 9)
11. 1 or 6 or 10
12. Randomized Controlled Trial/
13. random$.tw.
14. Major Clinical Study/
15. 12 or 13 or 14
16. Nonhuman/
17. editorial.pt.
18. 15 not (16 or 17)
19. 11 and 18
20. (2005$ or 2006$ or 2007$ or 2008$).em.
21. (2008$ or 2009$ or 2010).em,yr.
22. 20 or 21
23. 19 and 22
Science Citation Index Expanded and Social Sciences Citation Index, ISI
TS=(recruitment same “clinical trial”) or TS=(recruitment same “clinical trials”) or TS=(recruitment same “controlled trial”) or TS=
(recruitment same “controlled trials”)
ERIC, CSA
(recruit* or participat*) and ((clinical trial*) or (controlled
trial) or randomi*): Anywhere
National Research Register (NRR) Online
#1 CLINICAL TRIALS explode all trees (MeSH)
#2 recruit*
#3 #1 and #2
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C2-SPECTR
Recruitment
searched In All indexed fields OR in All non-indexed fields.
PubMed
Related articles to the 27 studies included in review version published in Issue 2 2010.
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Background
Randomised controlled trials are the gold-standard for the evaluation of the effectiveness and safety of healthcare interventions,
particularly because they protect against selection bias (Kunz 2002). However, recruiting clinicians and patients to randomised trials
can be extremely difficult.
Poor recruitment can lead to an underpowered study, which may report clinically relevant effects to be statistically non-significant. In
such cases it is important to bear in mind that ‘absence of evidence is not evidence of absence’ (Altman 1995). A non-significant finding
increases the risk that an effective intervention will be abandoned before its true value is established, or that there will be a delay in
demonstrating this value while more trials or meta-analyses are done. Underpowered trials also raise an ethical problem: trialists have
exposed participants to an intervention with uncertain benefit but may still be unable to determine whether an intervention does more
good than harm on completion of the trial. Poor recruitment can also lead to the trial being extended, which increases cost.
Although investigations of recruitment differ in their estimates of the proportion of studies that achieve their recruitment targets, it is
likely that less than 50% meet their target, or meet their target without extending the length of the trial (Charlson 1984; Haidich 2001;
Foy 2003; McDonald 2006). McDonald 2006, for example, found that of 114 trials, only 38 (31%) achieved their original recruitment
target and 65 (53%) were extended. The overall start to recruitment was delayed in 47 (41%) trials and early recruitment problems
were identified in 77 (63%) trials. Foy 2003 studied seven primary care trials of dyspepsia management and only one achieved its
recruitment target; five recruited less than 50% of their target and three of these closed prematurely because of recruitment problems.
Trialists use many interventions to improve recruitment (see for example Prescott 1999 andWatson 2006) but it is generally difficult to
predict the effect of these interventions. This Cochrane Methodology Review extends an earlier review by Mapstone et al (Mapstone),
which was last updated in February 2002, by adding an investigation of study setting on recruitment and by including more recently
published studies.
Objectives
The primary objective is to quantify the effects of strategies to improve recruitment of participants to randomised controlled trials. A
secondary objective is to assess the evidence for the effect of the research setting (e.g. primary care versus secondary care) on recruitment.
Criteria for considering studies for this review
Types of studies
Randomised and quasi-randomised controlled trials of interventions to improve recruitment to randomised controlled trials.
Types of participants
The randomised and quasi-randomised controlled trials of recruitment strategies should be set in the context of trials and are not
limited to healthcare; interventions that work in other fields could be applicable to healthcare settings. Research into ways to improve
questionnaire response and research looking at incentives and disincentives for clinicians to recruit patients to trials will be excluded,
as these issues are addressed by complementary Cochrane Methodology reviews (Edwards 2007; Rendell 2007). Strategies both within
real settings and in mock trials (studies that ask potential participants whether they would take part in a trial if it was run but the study
does not actually run the trial) will be eligible. Studies of retention strategies will be excluded.
Types of interventions
Any intervention aimed at improving recruitment of participants nestedwithin studies undertaken for other purposes. The interventions
being studied could be directed at research ethics committees (e.g. educational interventions that support the case for not requiring
mandatory signed, witnessed consent for recruitment to a trial), collaborators (e.g. clinicians recruiting patients for a trial) or study
participants (e.g. patients being randomised to a trial). Examples of such interventions are letters introducing the trial being signed by
eminent people or using university, public bodies or private letterheads, collaborators’ meetings and feedback, monetary incentives,
telephone follow up of expressions of interest, simplified consent procedures, pre-prepared research ethics committee documentation
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for collaborators, raffles for participants, recruitment co-ordinators in centres, use of media advertising, active versus passive case finding
methods and simplified protocols.
Types of outcome measures
Primary
Proportion of eligible individuals or centres contacted by the study authors who were actually recruited.
Proportion of patients with full follow-up.
Secondary
Rate at which participants were recruited.
Number and characteristics of people (participants, researchers, etc) who agree to take part.
Difficulties identified (including feelings of coercion or guilt).
Benefits identified (including feelings of altruism or being better cared for).
Search methods for identification of studies
To identify studies we will search bibliographic databases, look through reference lists of relevant systematic reviews and reference lists
of all included studies. We will contact authors of included studies and search the ISI Web of Science for records that have cited studies
included in the review. We will not apply any language or time restrictions.
We will search the following databases:
Cochrane Methodology Register (CMR)
Cochrane Central Register of Controlled Trials (CENTRAL)
MEDLINE, OVID 1950 to present
EMBASE, OVID 1980 to present
CINAHL, OVID 1982 to present
ERIC, CSA 1966 to present
PsycINFO, Ovid 1806 to present
C2-SPECTR
The National Research Register
ISI Web of Science Science Citation Index Expanded 1975 to present
ISI Web of Science Social Sciences Citation Index 1975 to present
Open-SIGLE (European grey literature) L’INstitut de l’Information Scientifique et Technique (INIST-CNRS)
The following MEDLINE search strategy, developed for SilverPlatter, will be adjusted according to the above listed databases.
A. (subject* near3 recruit) or (subject* near3 recruitment) or (subject* near3 participate) or (subject* near3 participation) or (subject*
near3 enro?l) or (subject* near3 enrol?ment) or (subject* near3 enlist)
B. (patient* near3 recruit) or (patient* near3 recruitment) or (patient* near3 participate) or (patient* near3 participation) or (patient*
near3 enro?l) or (patient* near3 enrol?ment) or (patient* near3 enlist)
C. (clinician* near3 recruit) or (clinician* near3 recruitment) or (clinician* near3 participate) or (clinician* near3 participation) or
(clinician* near3 enro?l) or (clinician* near3 enrol?ment) or (clinician* near3 enlist)
D. (doctor near3 recruit) or (doctor near3 recruitment) or (doctor near3 participate) or (doctor near3 participation) or (doctor near3
enro?l) or (doctor near3 enrol?ment) or (doctor near3 enlist)
E. (doctors near3 recruit) or (doctors near3 recruitment) or (doctors near3 participate) or (doctors near3 participation) or (doctors
near3 enro?l) or (doctors near3 enrol?ment) or (doctors near3 enlist)
F. (physician* near3 recruit) or (physician* near3 recruitment) or (physician* near3 participate) or (physician* near3 participation) or
(physician* near3 enro?l) or (physician* near3 enrol?ment) or (physician* near3 enlist)
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G. (experimenter* near3 recruit) or (experimenter* near3 recruitment) or (experimenter* near3 participate) or (experimenter* near3
participation) or (experimenter* near3 enro?l) or (experimenter* near3 enrol?ment) or (experimenter* near3 enlist)
H. (researcher* near3 recruit) or (researcher* near3 recruitment) or (researcher* near3 participate) or (researcher* near3 participation)
or (researcher* near3 enro?l) or (researcher* near3 enrol?ment) or (researcher* near3 enlist)
I. (investigator* near3 recruit) or (investigator* near3 recruitment) or (investigator* near3 participate) or (investigator* near3 partici-
pation) or (investigator* near3 enro?l) or (investigator* near3 enrol?ment) or (investigator* near3 enlist)
J. (hospital* near3 recruit) or (hospital* near3 recruitment) or (hospital* near3 participate) or (hospital* near3 participation) or (hospital*
near3 enro?l) or (hospital* near3 enrol?ment) or (hospital* near3 enlist)
K. (center* near3 recruit) or (center* near3 recruitment) or (center* near3 participate) or (center* near3 participation) or (center* near3
enro?l) or (center* near3 enrol?ment) or (center* near3 enlist)
L. (centre* near3 recruit) or (centre* near3 recruitment) or (centre* near3 participate) or (centre* near3 participation) or (centre* near3
enro?l) or (centre* near3 enrol?ment) or (centre* near3 enlist)
M. (participant* near3 recruit) or (participant* near3 recruitment) or (participant* near3 participate) or (participant* near3 participa-
tion) or (participant* near3 enro?l) or (participant* near3 enrol?ment) or (participant* near3 enlist)
N. PATIENT SELECTION in MeSH
O. A or B or C or D or E or F or G or H or I or J or K or L or M or N
P. Cochrane optimally sensitive search strategy for identifying randomised clinical trials (Dickersin et al 1994)
Q. O and P
Methods of the review
Identifying trials
Two authors will independently screen the titles and abstracts of all records retrieved from the searches of the electronic bibliographic
databases. Any disagreements will be resolved through discussion and, if necessary, the involvement of a third author. The full text will
be obtained for studies that appear to meet the inclusion criteria. All potentially eligible studies will be independently assessed by two
authors to determine if they meet the inclusion criteria. Any disagreements will be resolved through discussion or the involvement of
a third author.
Assessment of methodological quality
The adequacy of allocation concealment (adequate, unclear and inadequate) will be assessed for each study (Schulz 1995). Other aspects
of methodological quality, such as completeness of reporting of results and loss to follow-up will also be considered. Completeness of
reporting will be assessed with reference to the ability to judge whether allocation was concealed (i.e. unclear for allocation concealment
implies incomplete reporting) but also with regard to clear information on participants, intervention, comparator and outcomemeasure.
Reporting of information on the flow of participants through the trial (e.g. from a CONSORT diagram) will be recorded.
Data on methodological quality will be presented in an additional table for all included studies. Results will be interpreted in light of
methodological quality but we will not exclude studies because of low quality. Concealment of allocation (adequate versus inadequate
or unclear) will be considered as a potential cause of heterogeneity in subgroup analysis if there are sufficient studies (see ‘Data analysis’).
Data extraction
A data extraction form will be developed to collect the information required for the outcome measures given under ‘Types of outcome
measures’. Data will be extracted independently from each article by two authors. Differences in data extraction will be resolved
by discussion or the involvement of a third author. We will contact the authors of reports of potentially relevant studies to obtain
information or data needed for the review that could not be found in the published reports. Data will be extracted on the method
evaluated; country in which the study was done; nature of population; nature of the study setting; nature of the study to be recruited
into, randomisation or quasi-randomisation method; numbers and proportions in each arm.
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Data analysis
Trials will be analysed according to the type of intervention (e.g. monetary incentives, letters). Interventions will be grouped when they
are similar in form and content. Continuous data will be combined using odds ratios or relative risks and 95% confidence intervals
generated. Continuous data will be combined and 95% confidence intervals will be calculated using weighted mean differences or
standardised mean differences if different scales have been used. A subgroup analysis will assess the recruitment interventions by target
groups (e.g. ethics committees, clinicians, patients) where sufficient studies are available. Statistical evidence of heterogeneity of results
of trials will be sought using the Chi2 test for heterogeneity and quantify the degree of heterogeneity observed in the results using
the I2 statistic (Higgins 2003). Where substantial heterogeneity was detected possible explanations will be investigated informally, and
the data summarised using a random-effects analysis if appropriate. The following explanations will be explored in subgroup analyses
where there are sufficient studies because we believe that these are plausible, potential explanations for heterogeneity:
Type of design used to evaluate recruitment strategies (randomised versus quasi-randomised) and concealment of allocation (adequate
versus inadequate or unclear).
Setting of the study recruiting participants (e.g. primary versus secondary care; healthcare versus non-healthcare settings).
Design of the study recruiting participants (e.g., randomised versus non-randomised studies, trials with placebo arms versus those
without).
Reporting (publication) bias will be investigated for the primary outcomes using a funnel plot where 10 or more studies are available.
Potential conflict of interest
None known.
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Glossary of selected terms
Control
In clinical trials comparing two or more interventions, a control is a person in the comparison group that receives a placebo, no
intervention, usual care or another form of care.
Primary care
Care provided in the community by generalists (e.g. general practitioners, or family doctors) who often act as the first point of contact
between a patient and the rest of the health service.
Secondary care
Care provided in hospitals by specialists. Patients often (but not always) need to contact a clinician in primary care before getting a
referral to secondary care.
Randomised controlled trial (RCT) (Synonym: randomised clinical trial)
An experiment in which investigators randomly allocate eligible people into intervention groups to receive or not to receive one or
more interventions that are being compared. The results are assessed by comparing outcomes in the treatment and control groups.
Statistical power
The probability that the null hypothesis will be rejected if it is indeed false. In studies of the effectiveness of healthcare interventions,
power is a measure of the certainty of avoiding a false negative conclusion that an intervention is not effective when in truth it is
effective. The power of a trial is determined by how large it is (the number of participants), the number of events (e.g. strokes) or the
degree of variation in a continuous outcome (such as weight), how small an effect one believes is important (i.e. the smallest difference
in outcomes between the intervention and the control groups that is considered to be important), and how certain one wants to be of
avoiding a false positive conclusion (i.e. the cut-off that is used for statistical significance).
Statistical significance
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An estimate of the probability of an association (effect) as large or larger than what is observed in a trial occurring by chance, usually
expressed as a P value. For example, a P value of 0.049 for a risk difference of 10%means that there is less than a one in 20 (0.05) chance
of an association that is as large or larger having occurred by chance and it could be said that the results are ’statistically significant’ at
P = 0.05). The cut-off for statistical significance is usually taken at 0.05, but sometimes at 0.01 or 0.10.These cut-offs are arbitrary
and have no specific importance. Although it is often done, it is inappropriate to interpret the results of a trial differently according to
whether the P value is, say, 0.055 or 0.045 (which are quite similar values, not diametrically opposed ones).
F E E D B A C K
Michaels, 2 March 2010
Summary
I suggest that the next iteration of this report take into account, assuming it does exist in the literature, researcher relationships with
the community. I am not only referring to Community Based Participatory Research (CBPR) in relation to clinical research (see
www.communitiespartners.org), but also to researcher relationships with referring physicians and community based organizations.
These relationships are critical to the success of clinical research, especially in the community setting.
The review also needs to take into account disease states in terms of recruitment. The patient with controllable diabetes vs the patient
needing cancer treatment have very different information needs when it comes to clinical trial participation.
Submitter agrees with default conflict of interest statement:
I certify that I have no affiliations with or involvement in any organization or entity with a financial interest in the subject matter of
my feedback.
(Feedback submitted by Margo Micheals March 2010)
Reply
Many thanks for this suggestion, which we would like to build into our review. In terms of managing this, we think the best way to
incorporate this comment would be to create a new category of intervention where researchers have specifically evaluated the impact
on recruitment of building close collaborative relationships with potential participants, be they patients, healthy volunteers, or health
professionals. Here we would be looking to studies that compared such an intervention against what might be called traditional
recruitment strategies. We will also add disease as a potential subgroup analysis. We agree that it is highly plausible that disease (especially
chronic versus acute) plays a role in recruitment.
As you mention, we may not find primary studies that allow us to act on these suggestions straight away. We did not identify studies
that evaluated the kind of interventions mentioned above in our initial search though this may change as the review is updated.
Thanks again for your interest in our review.
Contributors
Reply received from the review team, April 2010.
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WH A T ’ S N E W
Last assessed as up-to-date: 31 May 2010.
Date Event Description
10 June 2011 New search has been performed Review updated: search extended to April 2010, 18 additional included studies.
While new studies were added to the review, the overall picture with regard to
interventions to improve recruitment to trials remains similar to the previous
version of the review
H I S T O R Y
Protocol first published: Issue 3, 2002
Review first published: Issue 1, 2004
Date Event Description
16 April 2010 Feedback has been incorporated Feedback fromMargoMichaels added with reply from
authors.
10 November 2009 New citation required but conclusions have not
changed
The title of this review has changed, as have the au-
thors.
10 November 2009 New search has been performed New search conducted September 2007. Twelve new
studies identified
27 December 2007 Amended Converted to new review format.
20 February 2007 New citation required and conclusions have changed Substantive amendment.
C O N T R I B U T I O N S O F A U T H O R S
Shaun Treweek, Jonathan Cook, Catherine Jackson, Marit Johansen, Ritu Jones, Monica Kjeldstrøm, Marie Pitkethly, Frank Sullivan
and Sue Wilson contributed to study design, record screening, reviewing full-text articles and drafting of the report. Shaun Treweek,
Pauline Lockhart, Elizabeth Mitchell and Marie Pitkethly extracted the data. Jonathan Cook and Shaun Treweek analysed the data.
Marit Johansen developed and ran the electronic searches. Pauline Lockhart, Elizabeth Mitchell and Taina Taskila contributed to record
screening, reviewing full-text articles and drafting of the report. Marie Pitkethly checked the reference lists of review articles identified
by the search.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We have not considered one of the primary outcomes and three of the secondary outcomes listed in our protocol:
Primary outcome:
• Proportion of patients with full follow-up.
Secondary outcomes:
• Number and characteristics of the different types of people (participants, researchers, etc) who agree to take part.
• Difficulties identified (including feelings of coercion or guilt).
• Benefits identified (including feelings of altruism or being better cared for).
Once an individual has been recruited the effect on follow-up (if any) of an intervention is a retention issue and there is now a Cochrane
protocol on retention strategies in trials (Brueton 2011). We have therefore decided to remove this primary outcome from our review.
With regard to the secondary outcomes listed above, very few of our included studies reported these outcomes, while a large number
of the studies we rejected did. We now believe that these outcomes would be better reported as primary outcomes in a different review.
I N D E X T E R M S
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Medical Subject Headings (MeSH)
∗Patient Selection; ∗Randomized Controlled Trials as Topic; Patient Education as Topic; Sample Size
MeSH check words
Humans
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